logoCabeceraNinos

Hemos leído sobre ... Artritis Inflamatorias

Última actualización: 16 Junio 2017

 
MAYO 2017
  • Imane Elbinoune; Bouchra Amine; Samira Rostom; Siham Shyen; Dalal Elbadri; Majda Ezzahri; Nada Mawani; Fanata Moussa; Sanae Gueddari; Wabi Moudjibou; Mariam Erraoui; Jihane Bahha; Redouane Abouqal; Bouchra Chkirate; Najia Hajjaj-Hassouni
    Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis.
    Ann Paediatr Rheum. 2017; 5(3): 71-78
    https://www.ncbi.nlm.nih.gov/pubmed/?term=16782733
  • Berard RA, Laxer RM.
    Learning the hard way: clinical trials in juvenile idiopathic arthritis.
    Ann Rheum Dis. 2017 May 25. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28546255
  • Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.
    Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.
    https://www.ncbi.nlm.nih.gov/pubmed/27564918
  • Gmuca S, Xiao R, Brandon TG, Pagnini I, Wright TB, Beukelman T, Morgan EM, Weiss PF.
    Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.
    Arthritis Res Ther. 2017 May 2;19(1):84. doi: 10.1186/s13075-017-1297-x.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=PMC5414167
  • Giancane G, Alongi A, Ravelli A.
    Update on the pathogenesis and treatment of juvenile idiopathic arthritis.
    Curr Opin Rheumatol. 2017 May 22. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28538013
  • Kindgren E, Fredrikson M, Ludvigsson J.
    Early feeding and risk of Juvenile idiopathic arthritis: a case control study in a prospective birth cohort.
    Pediatr Rheumatol Online J. 2017 May 26;15(1):46. doi: 10.1186/s12969-017-0175-z.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28549465
  • Schlichtiger J, Haas JP, Barth S, Bisdorff B, Hager L, Michels H, Hügle B, Radon K.
    Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population.
    Pediatr Rheumatol Online J. 2017 May 22;15(1):45. doi: 10.1186/s12969-017-0172-2.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28532479
  • Coda A, Sculley D, Santos D, Girones X, Brosseau L, Smith DR, Burns J, Rome K, Munro J, Singh-Grewal D.
    Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2017 May 16;15(1):40. doi: 10.1186/s12969-017-0168-y.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28511689
  • Ključevšek D, Emeršič N, Toplak N, Avčin T.
    Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course.
    Pediatr Rheumatol Online J. 2017 May 15;15(1):38. doi: 10.1186/s12969-017-0173-1.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28506237
  • Bell SW, Shenoi S, Nelson JL, Bhatti P, Mueller BA.
    Juvenile idiopathic arthritis in relation to perinatal and maternal characteristics: a case control study.
    Pediatr Rheumatol Online J. 2017 May 11;15(1):36. doi: 10.1186/s12969-017-0167-z.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28494794
  • Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.
    Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
    Rheumatology (Oxford). 2017 Jun 3. doi: 10.1093/rheumatology/kex206. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28582527
  • Alberdi-Saugstrup M1,2,3, Zak M4, Nielsen S4, Herlin T5, Nordal E6, Berntson L7, Fasth A8, Rygg M9,10, Klaus Müller4,11; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
    Rheumatol Int. 2017 May;37(5):695-703. doi: 10.1007/s00296-017-3657-x. Epub 2017 Mar 10.
    https://www.ncbi.nlm.nih.gov/pubmed/?term=28283733
  • Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K.
    Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Semin Arthritis Rheum. 2017 May 12
    https://www.ncbi.nlm.nih.gov/pubmed/28583690
 
ABRIL 2017
  • Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT.
    Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
    Rheumatology (Oxford). 2017 Apr 18. doi: 10.1093/rheumatology/kex049. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28431162
  • Rumsey DG, Guzman J, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, Bruns A, Feldman BM, Eurich DT; ReACCh-Out Investigators
    Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort.
    Arthritis Care Res (Hoboken). 2017 Apr 20. doi: 10.1002/acr.23256. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28426894
  • Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, Best B, Jones J, Schanberg LE; CARRA Registry Investigators
    The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
    Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30. doi: 10.1186/s12969-017-0160-6.
    https://www.ncbi.nlm.nih.gov/pubmed/28416023
  • Weiß A, Minden K, Listing J, Foeldvari I, Sieper J, Rudwaleit M.
    Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
    RMD Open. 2017 Mar 21;3(1):e000366. doi: 10.1136/rmdopen-2016-000366. eCollection 2017.
    https://www.ncbi.nlm.nih.gov/pubmed/28405472
  • Selvaag AM, Kirkhus E, Törnqvist L, Lilleby V, Aulie HA, Flatø B.
    Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.
    Pediatr Rheumatol Online J. 2017 Apr 11;15(1):20. doi: 10.1186/s12969-017-0151-7.
    https://www.ncbi.nlm.nih.gov/pubmed/28399930
  • Navallas M, Inarejos EJ, Iglesias E, Cho Lee GY, Rodríguez N, Antón J.
    MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings
    Radiographics. 2017 Mar-Apr;37(2):595-612. doi: 10.1148/rg.2017160078.
    https://www.ncbi.nlm.nih.gov/pubmed/28287946

MARZO 2017
  • Shoop-Worrall SJ, Verstappen SM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
    How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210511. doi: 10.1136/annrheumdis-2016-210511. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28389553
  • Roszkiewicz J, Smolewska E.
    In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Curr Rheumatol Rep. 2017 Apr;19(4):19. doi: 10.1007/s11926-017-0646-8
    https://www.ncbi.nlm.nih.gov/pubmed/28361333
  • Armbrust W, Bos GJ, Geertzen JH, Sauer PJ, Dijkstra PU, Lelieveld OT.
    Measuring Physical Activity in Juvenile Idiopathic Arthritis: Activity Diary Versus Accelerometer.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160671. doi: 10.3899/jrheum.160671. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28365580
  • Oen K, Guzman J, Dufault B, Tucker LB, Shiff NJ, Watanabe Duffy K, Lee JJ, Feldman BM, Berard RA, Dancey P, Huber AM, Scuccimarri R, Cabral DA, Morishita KA, Ramsey SE, Rosenberg AM, Boire G, Benseler SM, Lang B, Houghton K, Miettunen PM, Chédeville G, Levy DM, Bruns A, Schmeling H, Haddad E, Yeung RS, Duffy CM; Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) investigators.
    Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis.
    Arthritis Care Res (Hoboken). 2017 Mar 20. doi: 10.1002/acr.23236. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28320056
  • Alberdi-Saugstrup M, Zak M, Nielsen S, Herlin T, Nordal E, Berntson L, Fasth A, Rygg M, Klaus Müller; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
    Rheumatol Int. 2017 Mar 10. doi: 10.1007/s00296-017-3657-x.
    https://www.ncbi.nlm.nih.gov/pubmed/28283733
  • Hashaad NI, Fawzy RM, Elazem AA, Youssef MI.
    Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity.
    Eur J Rheumatol. 2017 Mar;4(1):19-23. doi: 10.5152/eurjrheum.2017.160071.
    https://www.ncbi.nlm.nih.gov/pubmed/28293448
  • Kwon HJ, Kim YL, Lee HS, Lee SM.
    A study on the physical fitness of children with juvenile rheumatoid arthritis.
    J Phys Ther Sci. 2017 Mar;29(3):378-383. doi: 10.1589/jpts.29.378.
    https://www.ncbi.nlm.nih.gov/pubmed/28356614
  • Frittoli RB, Longui BS, Silva AM, Filho AA, Monteiro MÂ, Appenzeller S.
    Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.
    Rev Bras Reumatol Engl Ed. 2017 Mar - Apr;57(2):100-106. doi: 10.1016/j.rbre.2016.07.009.
    https://www.ncbi.nlm.nih.gov/pubmed/28343613
  • Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D.
    Pro-inflammatory cytokine environments can drive IL-17 over-expression by γδT cells in systemicjuvenile idiopathic arthritis.
    Arthritis Rheumatol. 2017 Mar 15. doi: 10.1002/art.40099. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28296284
  • Lee M, Isaacs J.
    The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis.
    Eur J Rheumatol. 2017 Mar;4(1):68-69. doi: 10.5152/eurjrheum.2016.055.
    https://www.ncbi.nlm.nih.gov/pubmed/28293458

FEBRERO 2017
  • Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED; and the CARRA Legacy Registry Investigators.
    The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    J Rheumatol. 2017 Feb 1. pii: jrheum.160717. doi: 10.3899/jrheum.160717. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28148698
  • Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
    A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
    https://www.ncbi.nlm.nih.gov/pubmed/28166785
  • Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study.
    Pediatr Rheumatol Online J. 2017 Feb 22;15(1):13. doi: 10.1186/s12969-017-0145-5.
    https://www.ncbi.nlm.nih.gov/pubmed/28222745
  • Alberdi-Saugstrup M, Enevold C, Zak M, Nielsen S, Nordal E, Berntson L, Fasth A, Rygg M, Müller K; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome.
    Scand J Rheumatol. 2017 Feb 1:1-8. doi: 10.1080/03009742.2016.1238959. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28145159
  • Adriano LS, de França Fonteles MM, de Fátima Menezes Azevedo M, Beserra MP, Romero NR.
    Medication adherence in patients with juvenile idiopathic arthritis.
    Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
    https://www.ncbi.nlm.nih.gov/pubmed/28137399
  • Wulffraat N.
    The value of old drugs for juvenile idiopathic arthritis.
    Lancet. 2017 Feb 2. pii: S0140-6736(17)30180-0. doi: 10.1016/S0140-6736(17)30180-0. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28162780
  • Nusman CM, Hemke R, Lavini C, Schonenberg-Meinema D, van Rossum MA, Dolman KM, van den Berg JM, Maas M, Kuijpers TW.
    Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis.
    Eur J Radiol. 2017 Mar;88:77-81. doi: 10.1016/j.ejrad.2017.01.003. Epub 2017 Jan 4.
    https://www.ncbi.nlm.nih.gov/pubmed/28189212
  • Xia Y, Cui P, Li Q, Liang F, Li C, Yang J.
    Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
    Braz J Med Biol Res. 2017 Feb 16;50(2):e5958. doi: 10.1590/1414-431X20165958.
    https://www.ncbi.nlm.nih.gov/pubmed/28225869
  • Skrabl-Baumgartner A, Christine Hauer A, Erwa W, Jahnel J.
    HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis.
    Arch Dis Child. 2017 Feb 23. pii: archdischild-2016-311544. doi: 10.1136/archdischild-2016-311544. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28232458
  • Dewoolkar M, Cimaz R, Chickermane PR, Khubchandani RP.
    Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.
    Indian J Pediatr. 2017 Feb 23. doi: 10.1007/s12098-017-2293-5. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28229369
  • Wiens AD, Prahalad S, Inan OT, Wiens AD, Prahalad S, Inan OT, Wiens AD, Inan OT, Prahalad S.
    VibroCV: a computer vision-based vibroarthrography platform with possible application to Juvenile Idiopathic Arthritis.
    Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4431-4434. doi:10.1109/EMBC.2016.7591710.
    https://www.ncbi.nlm.nih.gov/pubmed/28227495
  • Park SK, Hwang PH, Yun SK, Kim HU, Park J.
    Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature.
    Ann Dermatol. 2017 Feb;29(1):74-78. doi: 10.5021/ad.2017.29.1.74. Epub 2017 Feb 3.
    https://www.ncbi.nlm.nih.gov/pubmed/28223750
  • Wang Y, Chen L, Li F, Bao M, Zeng J, Xiang J, Luo H, Li J, Tang L.
    TLR4 rs41426344 increases susceptibility of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in a central south Chinese Han population.
    Pediatr Rheumatol Online J. 2017 Feb 21;15(1):12. doi: 10.1186/s12969-017-0137-5.
    https://www.ncbi.nlm.nih.gov/pubmed/28222760
  • Adriano LS1, de França Fonteles MM2, de Fátima Menezes Azevedo M3, Beserra MP2, Romero NR2.
    Medication adherence in patients with juvenile idiopathic arthritis.
    Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
    https://www.ncbi.nlm.nih.gov/pubmed/28137399
  • Mizuta M, Shimizu M, Nakagishi Y, Kasai K, Yachie A.
    Bicipital synovial cyst associated with systemic juvenile idiopathic arthritis: new insights obtained from unique pathological findings.
    Int J Rheum Dis. 2017 Feb 10. doi: 10.1111/1756-185X.12994. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28185428
  • Hisa K, Yanagimachi MD, Naruto T, Miyamae T, Kikuchi M, Hara R, Imagawa T, Yokota S, Mori M.
    PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    PLoS One. 2017 Feb 9;12(2):e0171961. doi: 10.1371/journal.pone.0171961. eCollection 2017.
    https://www.ncbi.nlm.nih.gov/pubmed/28182665
  • Uziel Y.
    Juvenile Idiopathic Arthritis in the Era of International Cooperation.
    Rambam Maimonides Med J. 2017 Jan 30;8(1). doi: 10.5041/RMMJ.10278.
    https://www.ncbi.nlm.nih.gov/pubmed/28178439
  • Sarkar S, Alam MM, Das G, Datta S.
    Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
    Indian J Pediatr. 2017 Feb 8. doi: 10.1007/s12098-017-2292-6. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28176230
  • Stinson J, Connelly M, Huber A, Luca N, Spiegel L, Tsimicalis A, Luca S, Tajuddin N, Berard R, Barsalou J, Campillo S, Dancey P, Duffy C, Feldman B, Johnson N, McGrath P, Shiff N, Tse S, Tucker L, Victor J.
    Development and usability testing of an iPad and desktop psycho-educational game for children with Juvenile Idiopathic Arthritis and their parents.
    J Pain. 2016 Apr;17(4S):S106. doi: 10.1016/j.jpain.2016.01.335. Epub 2016 Mar 24.
    https://www.ncbi.nlm.nih.gov/pubmed/28162331
  • Srivastava R, Phatak S, Aggarwal A.
    ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis.
    Clin Rheumatol. 2017 Feb 4. doi: 10.1007/s10067-017-3560-6. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28161768
  • Macedo de Menezes L, Deon Rizzatto SM, Martinelli Santayana de Lima E, Baccarin Matje PR, Picarelli MM.
    Juvenile idiopatic arthritis in orthodontics: Case report with a 6-year follow-up.
    Am J Orthod Dentofacial Orthop. 2017 Feb;151(2):384-396. doi: 10.1016/j.ajodo.2015.12.032.
    https://www.ncbi.nlm.nih.gov/pubmed/28153169
  • Horton DB, Onel KB, Beukelman T, Ringold S.
    Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol. 2017 Feb 1. pii: jrheum.161078. doi: 10.3899/jrheum.161078. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28148696
  • Al-Mayouf SM, Naji H, Alismail K, Alazami AM, Sheikh F, Conca W, Al-Mousa H.
    Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis?
    Clin Exp Rheumatol. 2017 Jan 27. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28134088
  • Glerup M, Herlin T, Twilt M.
    Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
    Clin Rheumatol. 2017 Mar;36(3):671-676. doi: 10.1007/s10067-017-3540-x. Epub 2017 Jan 17.
    https://www.ncbi.nlm.nih.gov/pubmed/28097448
  • Pasini AM, Gagro A, Roić G, Vrdoljak O, Lujić L, Žutelija-Fattorini M.
    Ataxia Telangiectasia and Juvenile Idiopathic Arthritis.
    Pediatrics. 2017 Feb;139(2). pii: e20161279. doi: 10.1542/peds.2016-1279. Epub 2017 Jan 12.
    https://www.ncbi.nlm.nih.gov/pubmed/28082406
  • Merker J, Hartmann M, Kreuzpointner F, Schwirtz A, Haas JP.
    Excellent balance skills despite active and inactive juvenile idiopathic arthritis - unexpected results of a cross-sectional study.
    Clin Exp Rheumatol. 2017 Jan-Feb;35(1):161-168. Epub 2017 Jan 5.
    https://www.ncbi.nlm.nih.gov/pubmed/28079509
  • Nakamura H, Sugai T, Kato M, Hatanaka KC, Atsumi T
    Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis.
    Clin Exp Rheumatol. 2017 Jan-Feb;35(1):174. Epub 2017 Jan 5.
    https://www.ncbi.nlm.nih.gov/pubmed/28079502
  • Burden-Teh E, Thomas KS, Rangaraj S, Cranwell J, Murphy R.
    Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening.
    Clin Exp Dermatol. 2017 Mar;42(2):153-160. doi: 10.1111/ced.13010. Epub 2017 Jan 2.
    https://www.ncbi.nlm.nih.gov/pubmed/28044348

ENERO 2017
  • Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EH, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A; Italian Pediatric Rheumatology Study Group.
    Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. 
    Lancet. 2017 Feb 2. pii: S0140-6736(17)30065-X. doi: 10.1016/S0140-6736(17)30065-X. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28162781       
  • Taylor J, Giannini EH, Lovell DJ, Huang B, Morgan E.
     Lack of Concordance in Inter-Rater Scoring of the Provider's Global Assessment of Children with Juvenile Idiopathic Arthritis with Low Disease Activity.
    Arthritis Care Res (Hoboken). 2017 Jan 24. doi: 10.1002/acr.23203. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28118522
  • Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
    A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
    https://www.ncbi.nlm.nih.gov/pubmed/28166785
  • Aalto K, Lahdenne P, Kolho KL
    Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.
    Pediatr Rheumatol Online J. 2017 Jan 31;15(1):9. doi: 10.1186/s12969-016-0132-2.
    https://www.ncbi.nlm.nih.gov/pubmed/28143478
  • Glerup M, Herlin T, Twilt M.
    Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
    Clin Rheumatol. 2017 Jan 17. doi: 10.1007/s10067-017-3540-x. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28097448

DICIEMBRE 2016
  • Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.
    Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
    Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.
    https://www.ncbi.nlm.nih.gov/pubmed/27993144
  • Armbrust W, Lelieveld OH, Tuinstra J, Wulffraat NM, Bos GJ, Cappon J, van Rossum MA, Sauer PJ, Hagedoorn M.
    Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation.
    Pediatr Rheumatol Online J. 2016 Dec 6;14(1):65.
    https://www.ncbi.nlm.nih.gov/pubmed/27919265
  • Hinks A, Bowes J, Cobb J, Ainsworth HC, Marion MC, Comeau ME, Sudman M, Han B; Juvenile Arthritis Consortium for Immunochip., Becker ML, Bohnsack JF, de Bakker PI, Haas JP, Hazen M, Lovell DJ, Nigrovic PA, Nordal E, Punnaro M, Rosenberg AM, Rygg M, Smith SL, Wise CA, Videm V, Wedderburn LR, Yarwood A, Yeung RS, Prahalad S, Langefeld CD, Raychaudhuri S, Thompson SD, Thomson W.
    Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.
    Ann Rheum Dis. 2016 Dec 20.
    https://www.ncbi.nlm.nih.gov/pubmed/27998952
  • Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group., Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.
    Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
    Ann Rheum Dis. 2016 Dec 7
    https://www.ncbi.nlm.nih.gov/pubmed/27927641
  • Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, Niehues T, Hufnagel M, Thon A, Hospach T, Horneff G, Minden K.
    Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
    Arthritis Rheumatol. 2016 Dec;68(12):3023-3034.
    https://www.ncbi.nlm.nih.gov/pubmed/27332999
  • Resnick CM, Vakilian PM, Breen M, Zurakowski D, Caruso P, Henderson L, Nigrovic PA, Kaban LB, Peacock ZS.
    Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2016 Dec;68(12):1795-1802.
    https://www.ncbi.nlm.nih.gov/pubmed/27110936
  • Luca NJ, Burnett HF, Ungar WJ, Moretti ME, Beukelman T, Feldman BM, Schwartz G, Bayoumi AM.
    Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Plyarticular Juvenile Idiopathic Arthritis
    Arthritis Care Res (Hoboken). 2016 Dec;68(12):1803-1811.
    https://www.ncbi.nlm.nih.gov/pubmed/27059807
  • Horneff G, Klein A, Oommen PT, Hospach A, Foeldvari I, Feddersen I, Minden K.
    Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry.
    Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1113-1120.
    https://www.ncbi.nlm.nih.gov/pubmed/27749226
  • Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Benseler SM, Tucker LB; on behalf of the ReACCh-Out Investigators.
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2016 Dec 15.
    https://www.ncbi.nlm.nih.gov/pubmed/27980015

NOVIEMBRE 2016
  • Kallinich T, Thorwarth A, von Stuckrad SL, Rösen-Wolff A, Luksch H, Hundsdoerfer P, Minden K, Krawitz P.
    Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.
    Pediatr Rheumatol Online J. 2016 Nov 24;14(1):63.
    https://www.ncbi.nlm.nih.gov/pubmed/27881174
  • Lipinska J, Lipinska S, Kasielski M, Smolewska E.
    Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Clin Rheumatol. 2016 Nov;35(11):2699-2706.
    https://www.ncbi.nlm.nih.gov/pubmed/27457366
  • Horneff G, Klein A, Klotsche J, Minden K, Huppertz HI, Weller-Heinemann F, Kuemmerle-Deschner J, Haas JP, Hospach A.
    Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.
    Arthritis Res Ther. 2016 Nov 24;18(1):272.
    https://www.ncbi.nlm.nih.gov/pubmed/27881144
  • Nozawa T, Nishimura K, Ohara A, Hara R, Ito S.
    Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
    Mod Rheumatol. 2016 Nov 16:1-19.
    https://www.ncbi.nlm.nih.gov/pubmed/27846755
  • Bohr AH, Pedersen FK, Nielsen CH, Müller KG.
    Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study.
    Pediatr Rheumatol Online J. 2016 Nov 11;14(1):61.
    https://www.ncbi.nlm.nih.gov/pubmed/27835952
  • Capone M, Maggi L, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Cimaz R, Ramazzotti M, Piccinni MP, Barra G, De Palma R, Liotta F, Maggi E, Romagnani S, Annunziato F, Cosmi L.
    Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients.
    Clin Mol Allergy. 2016 Nov 8;14:16.
    https://www.ncbi.nlm.nih.gov/pubmed/27826220
  • Maggi L, Cimaz R, Capone M, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Pagnini I, Giani T, Simonini G, Scaletti C, Liotta F, Maggi E, Annunziato F, Cosmi L.
    Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients.
    Int Arch Allergy Immunol. 2016;171(1):45-53.
    https://www.ncbi.nlm.nih.gov/pubmed/27820937
  • Nisihara R, Skare T, Jardim AC, Utiyama SR.
    Celiac disease autoantibodies in juvenile idiopathic arthritis.
    Rheumatol Int. 2016 Nov 2.
    https://www.ncbi.nlm.nih.gov/pubmed/27807636
  • Tu ZQ, Xue HY, Chen W, Cao LF, Zhang WQ.
    Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.
    Rheumatol Int. 2016 Nov 19.
    https://www.ncbi.nlm.nih.gov/pubmed/27866247

OCTUBRE 2016
  • Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Baildam E, Beresford MW, Foster HE, Douglas S, Thomson W, De Cock D; BCRD Study Group.; BSPAR-ETN Study Group., Hyrich KL.
    Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.
    Arch Dis Child. 2016 Oct 31
    https://www.ncbi.nlm.nih.gov/pubmed/27799155
  • Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
    Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)
    Semin Arthritis Rheum. 2016 Oct;46(2):190-5
    https://www.ncbi.nlm.nih.gov/pubmed/27422803
  • Geven EJ, van den Bosch MH, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schäfers M, van de Loo FA, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PL.
    S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis
    Arthritis Res Ther. 2016 Oct 24;18(1):247
    https://www.ncbi.nlm.nih.gov/pubmed/27776554

SEPTIEMBRE 2016
  • Cellucci T, Guzman J, Petty RE, Batthish M, Benseler SM, Ellsworth JE, Houghton KM, LeBLANC CM, Huber AM, Luca N, Schmeling H, Shiff NJ, Soon GS, Tse SM. Pediatric Committee of the Canadian Rheumatology Association.
    Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
    J Rheumatol. 2016 Oct;43(10):1773-1776.
    https://www.ncbi.nlm.nih.gov/pubmed/27698103
  • Windschall D, Horneff G.
    Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
    Clin Rheumatol. 2016 Oct 5.
    https://www.ncbi.nlm.nih.gov/pubmed/27709443
  • Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D.
    The human microbiome and juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Sep 20;14(1):55.
    https://www.ncbi.nlm.nih.gov/pubmed/27650128
  • Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR.
    The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.
    Arthritis Res Ther. 2016 Sep 22;18(1):210.
    https://www.ncbi.nlm.nih.gov/pubmed/27655411
  • Aupiais C, Basmaci R, Ilharreborde B, Blachier A, Desmarest M, Job-Deslandre C, Faye A, Bonacorsi S, Alberti C, Lorrot M.
    Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis.
    Arch Dis Child. 2016 Sep 21.
    https://www.ncbi.nlm.nih.gov/pubmed/27655660
  • Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, Ziaee V, Rezaei N.
    Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population.
    Fetal Pediatr Pathol. 2016 Oct 12:1-7
    https://www.ncbi.nlm.nih.gov/pubmed/27732119
  • Ziaee V, Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Rezaei N.
    Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population.
    Allergol Immunopathol (Madr). 2016 Oct 4.
    https://www.ncbi.nlm.nih.gov/pubmed/27717726
  • Isola G1, Ramaglia L, Cordasco G, Lucchese A, Fiorillo L, Matarese G.
    The effect of a functional appliance in the management of temporomandibular
    joint disorders in patients with juvenile idiopathic arthritis.
    Minerva Stomatol. 2016 Sep 13.
    https://www.ncbi.nlm.nih.gov/pubmed/27716739
  • Gaur P, Myles A, Misra R, Aggarwal A.
    Intermediate monocytes are increased in Enthesitis Related Arthritis a category of Juvenile idiopathic arthritis.
    Clin Exp Immunol. 2016 Oct 5.
    https://www.ncbi.nlm.nih.gov/pubmed/27706807
  • Armbrust W, Joyce Bos GJ, Wulffraat NM, van Brussel M, Cappon J, Dijkstra PU, Geertzen JH, Legger GE, van Rossum MA, Sauer PJ, Lelieveld OT.
    Internet program for physical activity and exercise capacity in children with juvenile idiopathic arthritis: a multicenter randomized controlled trial.
    Arthritis Care Res (Hoboken). 2016 Oct 1.
    https://www.ncbi.nlm.nih.gov/pubmed/27696793
  • Put K, Vandenhaute J, Avau A, Van Nieuwenhuijze A, Brisse E, Dierckx T, Rutgeerts O, Garcia-Perez J, Toelen J, Waer M, Leclercq G, Goris A, Van Weyenbergh J, Liston A, de Somer L, Wouters C, Matthys P11.
    Inflammatory gene expression profile and defective IFN-γ and granzyme K in natural killer cells of systemic juvenile idiopathic arthritis patients.
    Arthritis Rheumatol. 2016 Oct 1.
    https://www.ncbi.nlm.nih.gov/pubmed/27696741
  • Memari AH, Chamanara E, Ziaee V, Kordi R, Raeeskarami SR.
    Behavioral Problems in Juvenile Idiopathic Arthritis: A Controlled Study to Examine the Risk of Psychopathology in a Chronic Pediatric Disorder.
    Int J Chronic Dis. 2016;2016:5726236.
    https://www.ncbi.nlm.nih.gov/pubmed/27656678
  • Lantz JM, Joshi S, OʼHearn M.
    The Effects of Orthopedic Manual Physical Therapy in the Management of Juvenile Idiopathic Arthritis: A Case Report.
    Pediatr Phys Ther. 2016 Winter;28(4):490-7.
    https://www.ncbi.nlm.nih.gov/pubmed/27661250
  • Maggi L, Cosmi L, Simonini G, Annunziato F, Cimaz R.
    T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies.
    Autoimmun Rev. 2016 Sep 15.
    https://www.ncbi.nlm.nih.gov/pubmed/27640318
  • Lipstein EA, Lovell DJ, Denson LA, Kim SC, Spencer C, Britto MT.
    Parents' information needs and influential factors when making decisions about TNF-α inhibitors.
    Pediatr Rheumatol Online J. 2016 Sep 15;14(1):53.
    https://www.ncbi.nlm.nih.gov/pubmed/27641835
  • Ziaee V, Maddah M, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Harsini S, Rezaei N.
    Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.
    Clin Rheumatol. 2016 Sep 20.
    https://www.ncbi.nlm.nih.gov/pubmed/27646136
  • Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE.
    Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.
    Emerg Infect Dis. 2016 Oct;22(10):1720-7.
    https://www.ncbi.nlm.nih.gov/pubmed/27648582
  • De Rosa G, De Nisco A, Piastra M, Valentini P, Rigante D.
    Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis.
    Reumatismo. 2016 Sep 9;68(2):114-5.
    https://www.ncbi.nlm.nih.gov/pubmed/27608803
  • Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope Rd CA.
    Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
    Clin Exp Rheumatol. 2016 Sep-Oct;34(5):946-952.
    https://www.ncbi.nlm.nih.gov/pubmed/27607024
  • Mannion ML, Xie F, Baddley J, Chen L, Curtis JR, Saag K, Zhang J, Beukelman T.
    Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.
    Pediatr Rheumatol Online J. 2016 Sep 5;14(1):49.
    https://www.ncbi.nlm.nih.gov/pubmed/27596158
  • Ibrahim EF, Rashid A, Thomas M.
    Linked semiconstrained and unlinked total elbow replacement in juvenile idiopathic arthritis: a case comparison series with mean 11.7-year follow-up.
    J Shoulder Elbow Surg. 2016 Aug 31.
    https://www.ncbi.nlm.nih.gov/pubmed/27592371

AGOSTO 2016
  • Weiss PF.
    Update on enthesitis-related arthritis.
    Curr Opin Rheumatol. 2016 Sep;28(5):530-6. 
    http://www.ncbi.nlm.nih.gov/pubmed/27466726
  • Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope CA.
    Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
    Clin Exp Rheumatol. 2016 Sep 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27607024  
  • Yokota S, Itoh Y, Morio T, et al
    Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
    Ann Rheum Dis 2016;75:1654-1660
    http://ard.bmj.com/content/75/9/1654.abstract
  • Kearsley-Fleet L, Davies R, Baildam E et al
    Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
    Rheumatology (Oxford) 2016; 55(9):1556-65.
    http://rheumatology.oxfordjournals.org/content/55/9/1556.abstract
  • Stinson J, Ahola Kohut S, Forgeron P, Amaria K, Bell M, Kaufman M, Luca N, Luca S, Harris L, Victor C, Spiegel L.
    The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis.
    Pediatr Rheumatol Online J. 2016 Sep 2;14(1):48.
    http://www.ncbi.nlm.nih.gov/pubmed/27590668
  • Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, Wang Z, Mpofu S.
    Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
    J Rheumatol. 2016 Sep;43(9):1713-7.
    http://www.ncbi.nlm.nih.gov/pubmed/27307536
  • Van der Heijde D, Landewé RB, Mease PJ, et al.
    Secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active Psoriatic Arthritis
    Arthritis Rheumatol 2016; 68 (8):1914-21.
    http://onlinelibrary.wiley.com/doi/10.1002/art.39685/pdf 
  • Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group.
    Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
    Ann Rheum Dis. 2016 Aug 23. pii: annrheumdis-2016-209709. doi: 10.1136/annrheumdis-2016-209709. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27553214
  • Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK,
    Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2016 Aug 26. doi: 10.1002/acr.23003. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27564918
  • Doğruel D, Yılmaz M, Bingöl G, Altıntaş DU, Güneşer Kendirli S.
    Fraction of exhaled nitric oxide as a predictor in juvenile idiopathic arthritis progression.
    Clin Rheumatol. 2016 Aug 10. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27511473
  • Peters S, Ota S, Bolous E, Reich E, Chait S, Feldman BM.
    The Responsiveness of the Modified Childhood Health Assessment Questionnaire.
    J Rheumatol. 2016 Aug 1. pii: jrheum.151139. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27481906
  • Thorsen SU, Pipper CB, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, Thygesen LC, Ascherio A, Svensson J.
    No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study.
    Scand J Rheumatol. 2016 Jul 27:1-8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27460412

JULIO 2016
  • Becker I, Horneff G.
    Risk of serious infection in juvenile idiopathic arthritis patients associated with TNF-inhibitors and disease activity in the German BIKER registry.
    Arthritis Care Res (Hoboken). 2016 Jul 7. doi: 10.1002/acr.22961. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27390133 
  • Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.
    Gut microbiota-host interactions and juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6.
    http://www.ncbi.nlm.nih.gov/pubmed/27448997
  • Bos GJ, Lelieveld OT, Armbrust W, Sauer PJ, Geertzen JH, Dijkstra PU.
    Physical activity in children with Juvenile Idiopathic Arthritis compared to controls.
    Pediatr Rheumatol Online J. 2016 Jul 7;14(1):42. doi: 10.1186/s12969-016-0102-8.
    http://www.ncbi.nlm.nih.gov/pubmed/27387754
  • Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T2, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.
    Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.
    Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.
    http://www.ncbi.nlm.nih.gov/pubmed/26815131
  • Gohar F, Kessel C, Lavric M, Holzinger D, Foell D.
    Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?
    Arthritis Res Ther. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z.
    http://www.ncbi.nlm.nih.gov/pubmed/27411444

JUNIO 2016
  • Díaz-Peña R, Vidal-Castiñeira JR, López-Vázquez A, López-Larrea C.
    HLA-B*40:01 Is Associated with Ankylosing Spondylitis in HLA-B27-positive Populations.
    J Rheumatol. 2016 Jun;43(6):1255-6. doi: 10.3899/jrheum.151096.
    http://www.ncbi.nlm.nih.gov/pubmed/27252503
  • Kristensen KD, Stoustrup P, Küseler A, Pedersen TK, Twilt M, Herlin T
    Clinical predictors of temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic literature review.
    Semin Arthritis Rheum. 2016 Jun;45(6):717-32. doi: 10.1016/j.semarthrit.2015.11.006
    http://www.ncbi.nlm.nih.gov/pubmed/26708936
  • Janow G, Schanberg LE, Setoguchi S, Hasselblad V, Mellins ED, Schneider R, Kimura Y; CARRA Legacy Registry Investigators.
    The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
    J Rheumatol. 2016 Jun 15. pii: jrheum.150997
    http://www.ncbi.nlm.nih.gov/pubmed/27307527
  • Walters HM, Pan N, Lehman TJ, Adams A, Kalliolias GD, Zhu YS, Santiago F, Nguyen J, Sitaras L, Cunningham-Rundles S, Walsh TJ, Toussi SS.
    The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
    Clin Exp Immunol. 2016 Jun;184(3):308-17. doi: 10.1111/cei.12782
    http://www.ncbi.nlm.nih.gov/pubmed/26934060
  • Zamora-Legoff JA, Krause ML, Crowson CS, Muskardin TW, Mason T, Matteson EL.
    Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
    Clin Rheumatol. 2016 Jun;35(6):1493-9. doi: 10.1007/s10067-016-3190-4
    http://www.ncbi.nlm.nih.gov/pubmed/26825065
  • Taddio A, Cattalini M, Simonini G, Cimaz R.
    Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
    Expert Rev Clin Immunol. 2016 Jun;12(6):641-9. doi:10.1586/1744666X.2016.1146132
    http://www.ncbi.nlm.nih.gov/pubmed/26809126
  • Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M
    Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
    Pediatr Res. 2016 Jun;79(6):895-901. doi: 10.1038/pr.2016.27.
    http://www.ncbi.nlm.nih.gov/pubmed/26882369

MAYO 2016
  • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G et al.
    Extended report: Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Ann Rheum Dis 2016;75:855-861. doi:10.1136/annrheumdis-annrheumdis-2014-206747.
    http://ard.bmj.com/content/75/5/855.abstract 
  • Demirkaya E, Lanni S, Bovis F, Galasso R, Ravelli A, Palmisani E, et al.
    A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis.
    Arthritis Rheumatol 68:1540–1550. doi:10.1002/art.39583
    http://onlinelibrary.wiley.com/doi/10.1002/art.39583/abstract 
  • Alcobendas R, Rodríguez-Vidal A, Pascual-Salcedo D, Murias S, Remesal A, Diego C, et al.
    Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot study.
    Clin Exp Rheumatol 2016 Apr 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27156742 
  • Akmatov M, Stumme M, Pessler F.
    Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012.
    Clin Exp Rheumatol. 2016 Apr 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27156925
  • Quartier P.
    Choice of biologic drug among children with juvenile idiopathic arthritis.
    Rheumatology first published online May 11, 2016. doi: 10.1093/rheumatology/kew209
    http://rheumatology.oxfordjournals.org/content/early/2016/05/11/rheumatology.kew209.extract 
  • Kearsley-Fleet L, Davies R, Lunt M, Southwood TR, Hyrich KL.
    Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
    Rheumatology (2016) 55 (5): 840-847. doi: 10.1093/rheumatology/kev434
    http://rheumatology.oxfordjournals.org/content/55/5/840.abstract

ABRIL 2016
  • Kinard BE, Bouloux GF, Prahalad S, Vogler L, Abramowicz S
    Arthroscopy of the Temporomandibular Joint in Patients With Juvenile Idiopathic Arthritis
    J Oral Maxillofac Surg. 2016 Jan 22. pii: S0278-2391(16)00120-8. doi: 10.1016/j.joms.2016.01.028. [Epub ahead of print]
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26896757
  • Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K.
    Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
    PLoS One. 2016 Apr 26;11(4):e0153267. doi: 10.1371/journal.pone.0153267. eCollection 2016.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27115139
  • Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, Ravelli A.
    Clinical outcome measures in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23. doi: 10.1186/s12969-016-0085-5. Review.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27089922
  • Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
    Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
    Eur J Health Econ. 2016 Apr 16. [Epub ahead of print]
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27086322
  • Livermore P, Eleftheriou D, Wedderburn LR.
    The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
    Pediatr Rheumatol Online J. 2016 Apr 12;14(1):21. doi: 10.1186/s12969-016-0083-7.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068023
  • Consolaro A, Ravelli A.
    Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas - Key to Understanding Etiology and Genetic Factors?
    J Rheumatol. 2016 Apr;43(4):683-5. doi: 10.3899/jrheum.160173.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27037240
  • El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
    Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
    J Craniomaxillofac Surg. 2016 May;44(5):597-607. doi: 10.1016/j.jcms.2016.01.014. Epub 2016 Feb 3.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26924432

MARZO 2016
  • Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
    J Rheumatol. 2016 Mar 1. pii: jrheum.150430. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26932344
  • McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
    Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
    Rheumatology (Oxford). 2016 Mar 25. pii: kew021. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27016664
  • Chan MO, Petty RE, Guzman J; ReACCh-Out Investigators.
    A Family history of Psoriasis in a first-degree relative in children with JIA: to include or exclude?
    J Rheumatol. 2016 Mar 15. pii: jrheum.150555. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26980584
  • Turnier JL, Brunner HI.
    Tocilizumab for treating juvenile idiopathic arthritis.
    Expert Opin Biol Ther. 2016 Apr;16(4):559-66. doi: 10.1517/14712598.2016.1150997
    http://www.ncbi.nlm.nih.gov/pubmed/26848760
  • Makay B, Gücenmez ÖA, Ünsal E.
    Inactive disease in Enthesitis-related Arthritis: Association of increased body mass index.
    J Rheumatol. 2016 Mar 15. pii: jrheum.151208. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26980582
  • Katsicas MM, Russo R.
    Biologic agents in juvenile spondyloarthropathies.
    Pediatr Rheumatol Online J. 2016 Mar 12;14(1):17. doi: 10.1186/s12969-016-0076-6
    http://www.ncbi.nlm.nih.gov/pubmed/26968522
  • Gómez-Ramírez O, Gibbon M, Berard R, Jurencak R, Green J, Tucker L, Shiff N, Guzman J
    A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Mar 9;14(1):13. doi: 10.1186/s12969-016-0073-9.
    http://www.ncbi.nlm.nih.gov/pubmed/26961237
  • Lin CH, Lin CL, Shen TC, Wei CC.
    Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study.
    Pediatr Rheumatol Online J. 2016 Mar 10;14(1):15. doi: 10.1186/s12969-016-0074-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26965056
  • Schulert GS, Fall N, Harley JB, Shen N, Lovell DJ, Thornton S, Grom AA.
    Monocyte microRNA expression in active systemic juvenile idiopathic arthritis implicates miR-125a-5p in polarized monocyte phenotypes.
    Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39694. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27014994
  • Finkel TH, Li J, Wei Z, Wang W, Zhang H, Behrens EM, et al.
    Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.
    BMC Med Genet. 2016 Mar 22;17(1):24. doi: 10.1186/s12881-016-0285-3.
    http://www.ncbi.nlm.nih.gov/pubmed/27005825

FEBRERO 2016
  • Clement CC, Moncriefe H, Lele A, Janow G, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L.
    Autoimmune response to transthyretin in juvenile idiopathic arthritis.
    JCI Insight. 2016 Feb;1(2). pii: e85633. Epub 2016 Feb 25.
    http://www.ncbi.nlm.nih.gov/pubmed/26973882
  • Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, Hügle B.
    Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Feb 29;14(1):11. doi: 10.1186/s12969-016-0071-y.
    http://www.ncbi.nlm.nih.gov/pubmed/26928923
  • El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
    Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
    J Craniomaxillofac Surg. 2016 Feb 3. pii: S1010-5182(16)00028-7. doi: 10.1016/j.jcms.2016.01.014. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26924432
  • Nicolai R, Cortis E, Ravà L, Bracaglia C, Pardeo M, Insalaco A, Buonuomo PS, Tozzi AE, De Benedetti F.
    Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.
    J Pediatric Infect Dis Soc. 2016 Mar;5(1):76-9. doi: 10.1093/jpids/piu078. Epub 2014 Jul 31.
    http://www.ncbi.nlm.nih.gov/pubmed/26908493
  • Race DL, Sims-Gould J, Tucker LB, Duffy CM, Feldman DE, Gibbon M, Houghton KM, Stinson JN, Stringer E, Tse SM, McKay HA.
    'It might hurt, but you have to push through the pain': Perspectives on physical activity from children with juvenile idiopathic arthritis and their parents.
    J Child Health Care. 2016 Feb 23. pii: 1367493516632616. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26907570
  • Fay M1, Rapley T, Foster H, Pain C, Gerrand C.
    Can Seeding in the Clinic Reach a Wide Audience? A Proof of Concept Study on Spreading a Health Message About Juvenile Idiopathic Arthritis Using a Shareable Online Video.
    Interact J Med Res. 2016 Feb 22;5(1):e6. doi: 10.2196/ijmr.4608.
    http://www.ncbi.nlm.nih.gov/pubmed/26903485
  • Mani P, Uno K, Duong M, Wolski K, Spalding S, Husni ME, Nicholls SJ.
    HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.
    Cardiovasc Diagn Ther. 2016 Feb;6(1):34-43. doi: 10.3978/j.issn.2223-3652.2015.12.14.
    http://www.ncbi.nlm.nih.gov/pubmed/26885490
  • Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M.
    Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
    Pediatr Res. 2016 Feb 16. doi: 10.1038/pr.2016.27. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26882369
  • Evensen K, Aulie HA, Rønning OM, Flatø B, Russell D.
    Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls.
    J Rheumatol. 2016 Feb 15. pii: jrheum.150499. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26879363
  • Fitzpatrick L, Broadaway KA, Ponder L, Angeles-Han ST, Jenkins K, Rouster-Stevens K, Pelajo CF, Conneely K, Epstein MP, Lopez-Benitez J,Vogler LB, Prahalad S; CARRA Registry Investigators.
    Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
    J Rheumatol. 2016 Feb 15. pii: jrheum.150891. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26879356
  • Aguiar F, Brito I.
    Structural damage to the hip in systemic juvenile idiopathic arthritis: A case of regression with Anakinra.
    Reumatol Clin. 2016 Feb 9. pii: S1699-258X(16)00004-8. doi: 10.1016/j.reuma.2015.12.007. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26872537
  • Lange L, Thiele GM, McCracken C, Wang G, Ponder LA, Angeles-Han ST, Rouster-Stevens KA, Hersh AO, Vogler LB, Bohnsack JF, Abramowicz S, Mikuls TR, Prahalad S.
    Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2016 Feb 9;14(1):8. doi: 10.1186/s12969-016-0068-6.
    http://www.ncbi.nlm.nih.gov/pubmed/26861944
  • Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, Reed AM, Flatø B.
    Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.
    Scand J Rheumatol. 2016 Feb 8:1-5. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26854592
  • van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M,Wulffraat NM.
    Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    Clin Exp Rheumatol. 2016 Jan-Feb;34(1):148-54. Epub 2016 Feb 2.
    http://www.ncbi.nlm.nih.gov/pubmed/26843067
  • Barth SSchlichtiger JBisdorff BHügle BMichels HRadon KHaas JP.
    Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study.
    Pediatr Rheumatol Online J. 2016 Feb 3;14(1):6. doi: 10.1186/s12969-016-0066-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26842529
  • Kapusta MA.
    A Portrait of Juvenile Arthritis with Multiple Joint Abnormalities.
    J Rheumatol. 2016 Feb;43(2):450-1. doi: 10.3899/jrheum.150356.
    http://www.ncbi.nlm.nih.gov/pubmed/26834249
  • Ehrmann Feldman D, Vinet É, Bernatsky S, Duffy C, Hazel B, Meshefedjian G, Sylvestre MP, Bérard A.
    Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Feb 1. pii: jrheum.150592. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26834215
  • Hsieh YJ, Darvann TA, Hermann NV, Larsen P, Liao YF, Bjoern-Joergensen J, Kreiborg S.
    Facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe temporomandibular joint involvement.
    Am J Orthod Dentofacial Orthop. 2016 Feb;149(2):182-91. doi: 10.1016/j.ajodo.2015.07.033.
    http://www.ncbi.nlm.nih.gov/pubmed/26827974
  • Macaubas C, Wong E, Zhang Y, Nguyen KD, Lee J, Milojevic D, Shenoi S, Stevens AM, Ilowite N, Saper V, Lee T, Mellins ED.
    Altered signaling in systemic juvenile idiopathic arthritis monocytes.
    Clin Immunol. 2016 Feb;163:66-74. doi: 10.1016/j.clim.2015.12.011. Epub 2015 Dec 31.
    http://www.ncbi.nlm.nih.gov/pubmed/26747737

ENERO 2016
  • Kearsley-Fleet L, Davies R, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL.
    Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.
    Rheumatology (Oxford). 2016 Jan 4. pii: kev429. [Epub ahead of print]
    http://rheumatology.oxfordjournals.org/content/early/2016/01/03/rheumatology.kev429.full.pdf+html
  • Hilderson D, Moons P, Van der Elst K, Luyckx K, Wouters C, Westhovens R.
    The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project.
    Rheumatology (Oxford). 2016 Jan;55(1):133-42. doi: 10.1093/rheumatology/kev284. Epub 2015 Aug 28.
    http://www.ncbi.nlm.nih.gov/pubmed/26320142

DICIEMBRE 2015

    • Esbjörnsson, A.-C., Iversen, M. D., André, M., Hagelberg, S., Schwartz, M. H. and Broström, E. W
      Effect of Intraarticular Corticosteroid Foot Injections on Walking Function in Children With Juvenile Idiopathic Arthritis

      Arthritis Care Res, 67: 1693–1701. doi: 10.1002/acr.22624
      http://www.ncbi.nlm.nih.gov/pubmed/26017638
    • Markula-Patjas K, Valta H, Pekkinen M, Andersson S, Aalto K, Lahdenne P, Viljakainen H, Mäkitie O.
      Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids

      Clin Exp Rheumatol. 2015 Nov-Dec;33(6):924-30
      http://www.ncbi.nlm.nih.gov/pubmed/26315132
    • Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A.
      HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India.
      Clin Exp Rheumatol. 2015 Nov-Dec;33(6):931-5.
      http://www.ncbi.nlm.nih.gov/pubmed/26314893
  • Nigrovic PA.
    Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

    Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15785-6. doi: 10.1073/pnas.1521837113.
    http://www.ncbi.nlm.nih.gov/pubmed/26677874
  • Stoustrup P, Kristensen KD, Küseler A, Pedersen TK, Herlin T
    Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.
    Pediatr Rheumatol Online J. 2015 Dec 21;13(1):62. doi: 10.1186/s12969-015-0060-6.
    http://www.ncbi.nlm.nih.gov/pubmed/26689191  
  • Mulligan K, Wedderburn LR, Newman S
    The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people.

    Pediatr Rheumatol Online J. 2015 Dec 12;13(1):58. doi: 10.1186/s12969-015-0052-6.
    http://www.ncbi.nlm.nih.gov/pubmed/26653415
  • Bohr AH, Nielsen S, Müller K, Karup Pedersen F, Andersen LB
    Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation.
    Pediatr Rheumatol Online J. 2015 Dec 10;13(1):57. doi: 10.1186/s12969-015-0053-5.
    http://www.ncbi.nlm.nih.gov/pubmed/26653716  
  • Keller H, Müller LM, Markic G, Schraner T, Kellenberger CJ, Saurenmann RK.
    Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2015 Dec 9;13(1):56. doi: 10.1186/s12969-015-0056-2.
    http://www.ncbi.nlm.nih.gov/pubmed/26646650
  • Brosseau L, Toupin-April K, Wells GA, Smith CA, Pugh AG, Stinson JN, Duffy CM, Gifford W, Moher D, Sherrington C, Cavallo S, De Angelis G, Loew L, Rahman P, Marcotte R, Taki J, Bisaillon J, King J, Coda A, Hendry GJ, Gauvreau J, Hayles M, Hayles K, Feldman B, Kenny GP, Li JX, Briggs AM, Martini R, Feldman DE, Maltais DB, Tupper S, Bigford S, Bisch M
    Ottawa Panel Evidence-Based Clinical Practice Guidelines for Foot Care in the Management of Juvenile Idiopathic Arthritis.
    Arch Phys Med Rehabil. 2015 Dec 17. pii: S0003-9993(15)01480-X. doi: 10.1016/j.apmr.2015.11.011.
    http://www.ncbi.nlm.nih.gov/pubmed/26707409
NOVIEMBRE 2015

  • Patompong Ungprasert, Narat Srivali, Charat Thongprayoon
    Risk of Cardiovascular Disease in Patients with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-analysis

    Ann Paediatr Rheum. 2015; 4(3): 48-52
    doi: 10.5455/apr.073020151756   
  • E H Pieter van Dijkhuizen, Nico M Wulffraat
    Extended report:Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review

    Ann Rheum Dis 2015;74:1996-2005 Published Online First: 24 June 2014 doi:10.1136/annrheumdis-2014-205265
    [Abstract]
  • S. Shenoi, M.L. Shaffer and C.A. Wallace
    Environmental risk factors and early life exposures for Juvenile Idiopathic Arthritis; a case: Control study
    Arthritis Care & Research
    DOI: 10.1002/acr.22806
    Abstract
  • Rubén Burgos-Vargas, Shirley M. L. Tse, Gerd Horneff, Aileen L. Pangan, Jasmina Kalabic, Sandra Goss, Kristina Unnebrink and Jaclyn K. Anderson
    A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis (pages 1503–1512)

    Arthritis Care & Research
    DOI: 10.1002/acr.22657
    Abstract
  • Aimee O. Hersh, Sampath Prahalad
    Immunogenetics of juvenile idiopathic arthritis: A comprehensive review

    Journal of Autoimmunity
    Volume 64, November 2015, Pages 113–124
  • Deborah Barthel, Gerd Ganser, Rolf-Michael Kuester, Nils Onken, Kirsten Minden, Hermann Josef Girschick, Anton Hospach, and Gerd Horneff
    Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics

    J Rheumatol November doi:10.3899/jrheum.140472
    Abstract
  • Janneke Anink, Femke H. M. Prince, Maryanne Dijkstra, Marieke H. Otten, Marinka Twilt, Rebecca ten Cate, Simone L. Gorter, Yvonne Koopman-Keemink, Marion A. J. van Rossum, Esther P. A. Hoppenreijs, and Lisette W. A. van Suijlekom-Smit
    Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register

    Rheumatology (2015) 54 (11): 1964-1969 doi:10.1093/rheumatology/kev195
    Abstract
  • Simon Tarp, Gil Amarilyo, Ivan Foeldvari, Robin Christensen, Jennifer M. P. Woo, Neta Cohen, Tracy D. Pope, and Daniel E. Furst
    Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials

    Rheumatology
    doi:10.1093/rheumatology/kev382
    Abstract               
  • Lucie Brosseau, Désirée B. Maltais, Glen P. Kenny, Ciarán M. Duffy, Jennifer Stinson, Sabrina Cavallo, Karine Toupin-April, Debbie Ehrmann Feldman, Annette Majnemer, Isabelle J. Gagnon, and Marie-Ève Mathieu
    What we can learn from existing evidence about physical activity for juvenile idiopathic arthritis?
    Rheumatology
    doi:10.1093/rheumatology/kev389
    Extract
OCTUBRE 2015
  • Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, Ten Cate R, Gorter SL, Koopman-Keemink Y, van Rossum MA, Hoppenreijs EP, van Suijlekom-Smit LW.
    Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
    Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195
    http://www.ncbi.nlm.nih.gov/pubmed/26078219
  • van Dijkhuizen EHP, Wulffraat NM.
    Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
    Ann Rheum Dis 2015;74:1996-2005
    http://ard.bmj.com/content/74/11/1996.abstract
  • Ravelli A, Consolaro A, Schiappapietra B, Martini A
    The conundrum of juvenile psoriatic arthritis
    Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):40-3. Epub 2015 Oct 15. Review
    http://www.ncbi.nlm.nih.gov/pubmed/26470604
  • Obeid J, Nguyen T, Cellucci T, Larché MJ, Timmons BW.
    Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study
    Pediatr Rheumatol Online J. 2015 Oct 12;13(1):41. doi: 10.1186/s12969-015-0038-4.
    http://www.ncbi.nlm.nih.gov/pubmed/26458943
  • Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.
    Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.
    Rheumatology (Oxford). 2015 Oct 7. pii: kev353. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26447164
  • Du N, Jiang K, Sawle AD, Frank MB, Wallace CA, Zhang A, Jarvis JN.
    Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis
    Genome Med. 2015 Oct 24;7(1):109.
    http://www.ncbi.nlm.nih.gov/pubmed/26497493
  • Barthel D, Ganser G, Kuester RM, Onken N, Minden K, Girschick HJ, Hospach A, Horneff G.
    Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
    J Rheumatol. 2015 Sep 15. pii: jrheum.140472.
    http://www.ncbi.nlm.nih.gov/pubmed/26373564

SEPTIEMBRE 2015
  • Ogdie A, Weiss P.
    The Epidemiology of Psoriatic Arthritis.
    Rheum Dis Clin North Am. 2015 Nov;41(4):545-68. doi: 10.1016/j.rdc.2015.07.001
    http://www.ncbi.nlm.nih.gov/pubmed/26476218
  • Taxter AJ, Wileyto EP, Behrens EM, Weiss PF.
    Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis
    J Rheumatol October 2015 42(10):1914-21;doi:10.3899/jrheum.150092
    http://www.jrheum.org/content/42/10/1914.abstract
  • Sieper J. van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, Berd Y, Bergman G, Curtis S, Tzontcheva A, Huyck S and Weng HH.
    A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis.
    Arthritis Rheumatol 2015;67(10):2702–12
    http://onlinelibrary.wiley.com/doi/10.1002/art.39257/epdf
  • Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, et al for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation
    Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
    Arthritis Rheumatol 2015;67(10):2759-70
    http://onlinelibrary.wiley.com/doi/10.1002/art.39234/epdf
  • Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Gilles Boire G, et al.
    The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
    Ann Rheum Dis 2015;74:1861-7 Published Online First: 13 June 2014
    http://ard.bmj.com/content/74/10/1854.abstract
  • Ogata A, Atsum Ti, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N et al.
    Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Arthritis Care Res (Hoboken). 2015 Oct;67(10):1354-62. doi: 10.1002/acr.22598.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22598/epdf
  • Yamasaki Y, Takei S, Imanaka H, Nerome Y, Kubota T, Nonaka Y, Akaike H, Takezaki T, Kawano Y.
    Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and Vascular Endothelial Growth Factor.
    Mod Rheumatol. 2015 Oct 16:1-23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26474088
  • Mourão AF, Santos MJ, Mendonça S, Oliveira-Ramos F, Salgado M, Estanqueiro P, Melo-Gomes J, Martins F, Lopes A, Bettencourt BF, Bruges-Armas J, Costa J, Furtado C, Figueira R, Brito I, Branco J, Fonseca JE, Canhão H
    Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.
    J Immunol Res. 2015;2015:706515. doi: 10.1155/2015/706515. Epub 2015 Oct 4
    http://www.ncbi.nlm.nih.gov/pubmed/26504858
  • Kanetaka T, Mori M, Nishimura KI, Nozawa T, Kikuchi M, Sakurai N, Hara R, Yamazaki K, Yokota S.
    Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis.
    Mod Rheumatol. 2015 Sep 29:1-6. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26417716
  • Hyrich KL, Baildam E, Pickford H, Chieng A, Davidson JE, Foster H, Gardner-Medwin J, Wedderburn LR, Thomson W.
    Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis.
    Arch Dis Child. 2015 Sep 14. pii: archdischild-2014-308117. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26369575

AGOSTO 2015
  • Dilandro G, De Cosmi V, Corona F, Torcoletti M, Petaccia A, Filocamo G, Budelli A, Agostoni C.
    May biscuits contribute to iron balance? An observation in children with juvenile idiopatic arthritis.
    Int J Food Sci Nutr. 2015 Aug 27:1-4. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26313813
  • Hersh AO, Prahalad S.
    Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.
    J Autoimmun. 2015 Aug 21. pii: S0896-8411(15)30020-2. doi: 10.1016/j.jaut.2015.08.002. EPUB ahead of print
    http://www.ncbi.nlm.nih.gov/pubmed/26305060
  • Steigerwald KA, Ilowite NT.
    Novel treatment options for juvenile idiopathic arthritis.
    Expert Rev Clin Pharmacol. 2015 Sep;8(5):559-73. doi: 10.1586/17512433.2015.1061428
    http://www.ncbi.nlm.nih.gov/pubmed/26294075
  • Lomholt JJ, Thastum M, Christensen AE, Leegaard A, Herlin T.
    Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: A study of feasibility and preliminary efficacy.
    Pediatr Rheumatol Online J. 2015 Aug 21;13:35. doi: 10.1186/s12969-015-0032-x.
    http://www.ncbi.nlm.nih.gov/pubmed/26293657
  • Chiaroni-Clarke RC, Li YR, Munro JE, Chavez RA, Scurrah KJ, Pezic A, Akikusa JD, Allen RC, Piper SE, Becker ML, Thompson SD, Lie BA, Flato B, Forre O, Punaro M, Wise C, Saffery R, Finkel TH, Hakonarson H, Ponsonby AL, Ellis JA.
    The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females.
    Genes Immun. 2015 Aug 20. doi:10.1038/gene.2015.32. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26291515
  • Ammerlaan JJ, Scholtus LW, Drossaert CH, van Os-Medendorp H, Prakken B, Kruize AA, Bijlsma JJ.
    Feasibility of a Website and a Hospital-Based Online Portal for Young Adults With Juvenile Idiopathic Arthritis: Views and Experiences of Patients.
    JMIR Res Protoc. 2015 Aug 14;4(3) doi:10.2196/resprot.3952.
    http://www.ncbi.nlm.nih.gov/pubmed/26276373
  • Mou Y, Zhang P, Li Q, Lin Z, Liao Z, Wei Q, Gu J.
    Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes.
    Biomed Res Int. 2015;2015:594878. doi:10.1155/2015/594878.EPUB 2015 Jul 26.
    http://www.ncbi.nlm.nih.gov/pubmed/26273634
  • Farr S, Girsch W.
    The Hand and Wrist in Juvenile Rheumatoid Arthritis.
    J Hand Surg Am. 2015 Aug 10. pii:S0363-5023(15)00826-6. doi: 10.1016/j.jhsa.2015.06.111. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26272796
  • Shenoi S, Ou JN, Ni C, Macaubas C, Gersuk VH, Wallace CA, Mellins ED, Stevens AM.
    Comparison of Biomarkers for Systemic Juvenile Idiopathic Arthritis.
    Pediatr Res. 2015 Aug 12. doi:10.1038/pr.2015.144. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26267155
  • Santos D, Silva C, Silva M.
    Oral health and quality of life of children and adolescents with juvenile idiopathic arthritis according to their caregivers' perceptions.
    Spec Care Dentist. 2015 Aug 8. doi:10.1111/scd.12129. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26255878
  • Devauchelle-Pensec V, Thepaut M, Pecquery R, Houx L.
    Managing monoarthritis in children.
    Joint Bone Spine. 2015 Aug 4. pii:S1297-319X(15)00110-4. doi: 10.1016/j.jbspin.2015.06.004. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26253943
  • Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH4, van Rossum MA5, Dolman KM, Hoppenreijs EP, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Vogl T, Gohar F, Foell D, Roth J, Holzinger D.
    MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.
    Arthritis Res Ther. 2015 Aug 7;17:200. doi:10.1186/s13075-015-0723-1.
    http://www.ncbi.nlm.nih.gov/pubmed/26249667  
  • Gaur P, Misra R, Aggarwal A.
    Natural Killer cells and gamma-delta T cells alterations in Enthesitis Related Arthritis category of Juvenile idiopathic arthritis.
    Clin Immunol. 2015 Aug 2. pii:S1521-6616(15)30015-2. doi: 10.1016/j.clim.2015.07.012. EPUB ahead of print
    http://www.ncbi.nlm.nih.gov/pubmed/26244610  
  • Leksell E, Hallberg U, Magnusson B, Ernberg M, Hedenberg-Magnusson B.
    Perceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study.
    J Oral Facial Pain Headache. 2015 Summer;29(3):223-30.doi: 10.11607/ofph.1293.
    http://www.ncbi.nlm.nih.gov/pubmed/26244430  
  • Aggarwal A, Misra DP.
    Enthesitis-related arthritis.
    Clin Rheumatol. 2015 Aug 2. EPUB ahead of print
    http://www.ncbi.nlm.nih.gov/pubmed/26233720  
  • Abdwani R, Abdalla E, Al Abrawi S, Al-Zakwani I
    Epidemiology of juvenile idiopathic arthritis in Oman.
    Pediatr Rheumatol Online J. 2015 Aug 1;13(1):33. doi:10.1186/s12969-015-0030-z.
    http://www.ncbi.nlm.nih.gov/pubmed/26232056

JULIO 2015
  • Weiss PF, Xiao R, Biko DM, Chauvin NA
    Sacroiliitis at diagnosis of juvenile spondyloarthritis assessed by radiography, magnetic resonance imaging, and clinical examination.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22665. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26212574
  • Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, Unnebrink K, Anderson JK
    A randomized, double-blind, placebo-controlled, multicenter study of adalimumab in pediatric patients with enthesitis-related arthritis.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22657. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26223543
  • Esbjörnsson AC, Aalto K, Broström EW, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L
    Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
    Clin Exp Rheumatol. 2015 Jul 23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26213158
  • Pardeo M, Pires Marafon D, Insalaco A, Bracaglia C, Nicolai R, Messia V, De Benedetti F.
    Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience.
    J Rheumatol. 2015 Aug;42(8):1523-7. doi: 10.3899/jrheum.141567. Epub 2015 Jun 1.
    http://www.ncbi.nlm.nih.gov/pubmed/26034148
  • Ilisson J, Zagura M, Zilmer K, Salum E, Heilman K, Piir A, Tillmann V, Kals J, Zilmer M, Pruunsild C
    Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
    Arthritis Res Ther. 2015 Jul 16;17:180. doi: 10.1186/s13075-015-0699-x.
    http://www.ncbi.nlm.nih.gov/pubmed/26179062
  • Armbrust W, Bos JJ, Cappon J, van Rossum MA, Sauer PJ, Wulffraat N, van Wijnen VK, Lelieveld OT.
    Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2015 Jul 23;13(1):31. doi: 10.1186/s12969-015-0029-5.
    http://www.ncbi.nlm.nih.gov/pubmed/26202161
  • Oren-Ziv A, Hoppenstein D, Shles A, Uziel Y.
    Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review.
    Pediatr Rheumatol Online J. 2015 Jul 4;13(1):28. doi: 10.1186/s12969-015-0021-0.
    http://www.ncbi.nlm.nih.gov/pubmed/26141717
  • Lochbühler N, Saurenmann RK, Müller L, Kellenberger CJ
    Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Aug;42(8):1514-22. doi: 10.3899/jrheum.141502. Epub 2015 Jun 1.
    http://www.ncbi.nlm.nih.gov/pubmed/26034145

JUNIO 2015
  • Calvo I, Antón J, López Robledillo JC, de Inocencio J, Gamir ML, Merino R, Lacruz L, Camacho M, Rua MJ, Bustabad S, Díaz Cordovés-Rego G.
    Recomendaciones para el uso de metotrexato en pacientes con artritis idiopática juvenil.
    An Pediatr (Barc). 2015 Jun 12. pii: S1695-4033(15)00223-4. doi: 10.1016/j.anpedi.2015.05.005.
    http://www.ncbi.nlm.nih.gov/pubmed/26077957 
  • Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PA, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Østergaard M.
    EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
    Ann Rheum Dis. 2015 Jul;74(7):1327-1339. doi: 10.1136/annrheumdis-2014-206971.
    http://www.ncbi.nlm.nih.gov/pubmed/25837448
  • Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, van Eijk-Hustings Y, Gossec L, Korandová J, Mendes G, Niedermann K, Primdahl J, Stoffer M, Voshaar M, van Tubergen A.
    EULAR recommendations for patient education for people with inflammatory arthritis.
    Ann Rheum Dis. 2015 Jun;74(6):954-62. doi: 10.1136/annrheumdis-2014-206807.
    http://www.ncbi.nlm.nih.gov/pubmed/25735643
  • Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
    Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641.
    http://www.ncbi.nlm.nih.gov/pubmed/24641940
  • Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D,Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation PRINTO and the Pediatric Rheumatology Collaborative Study Group PRCSG.
    Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
    Ann Rheum Dis. 2015 Jun;74(6):1110-7. doi: 10.1136/annrheumdis-2014-205351.
    http://www.ncbi.nlm.nih.gov/pubmed/24834925
  • Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA
    Sibling Exposure and Risk of Juvenile Idiopathic Arthritis
    Arthritis Rheumatol. 2015 Jul;67(7):1951-8
    http://www.ncbi.nlm.nih.gov/pubmed/25809130
  • Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
    Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
    Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457.
    http://www.ncbi.nlm.nih.gov/pubmed/25504896
  • Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
    Impact of JIA on parents' work absences.
    Rheumatology (Oxford). 2015 Jul;54(7):1177-85. doi: 10.1093/rheumatology/keu414.
    http://www.ncbi.nlm.nih.gov/pubmed/25504895
  • Gmuca S, Weiss PF.
    Juvenile spondyloarthritis.
    Curr Opin Rheumatol. 2015 Jul;27(4):364-72. doi: 10.1097/BOR.0000000000000185.
    http://www.ncbi.nlm.nih.gov/pubmed/26002028

MAYO 2015

ABRIL 2015
  • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
    Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Ann Rheum Dis. 2015 Apr 29. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. 
    http://www.ncbi.nlm.nih.gov/pubmed/25926155
  • Martini G, Biscaro F, Boscaro E, Calabrese F, Lunardi F, Facco M, Agostini C, Zulian F, Fadini GP.
    Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    BMC Musculoskelet Disord. 2015 Apr 30;16(1):103. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25925313
  •  Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
    Efficacy and safety of etanercept in enthesitis-related arthritis juvenile idiopathic arthritis: Results from a phase 3 randomized double-blind study.
    Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39145. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25891010
  •  Scardapane A, Ferrante R, Nozzi M, Savino A, Antonucci I, Dadorante V, Balsamo M, Stuppia L, Chiarelli F, Breda L.
    TNF-α gene polymorphisms and juvenile idiopathic arthritis: Influence on disease outcome and therapeutic response.
    Semin Arthritis Rheum. 2015 Feb 19. pii: S0049-0172(15)00013-X. doi: 10.1016/j.semarthrit.2015.02.003. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25837015

MARZO 2015
    • Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA.
      Sibling exposure and risk of juvenile idiopathic arthritis in the ChiLdhood Arthritis Risk factor Identification sTudY (CLARITY).
      Arthritis Rheumatol. 2015 Mar 25. doi: 10.1002/art.39129. [Epub ahead of print]
      http://www.ncbi.nlm.nih.gov/pubmed/25809130
    • Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P.
      Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group's Greater Susceptibility to Infections?
      J Rheumatol. 2015 Mar;42(3):521-6. doi: 10.3899/jrheum.14034
      http://www.ncbi.nlm.nih.gov/pubmed/25320218
    • Chickermane PR, Khubchandani RP.
      Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
      Clin Exp Rheumatol. 2015 Feb 18. [Epub ahead of print]
      http://www.ncbi.nlm.nih.gov/pubmed/25738527
    • Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
      Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
      J Rheumatol. 2015 Mar;42(3):527-33. doi: 10.3899/jrheum.140073.
      http://www.ncbi.nlm.nih.gov/pubmed/25433530
    • Mease P, Sieper J, Van den Bosch F, Rahman P, Karunaratne PM, Pangan AL.
      Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
      Arthritis Rheum 2015 Apr; 67(4):914-923. DOI: 10.1002/art.39008
      http://onlinelibrary.wiley.com/doi/10.1002/art.39008/epdf
    • Deodhar A, Braun J, Inman RD, van der Heijde D, Zhou Y, Xu S, Han C, Hsu B
      Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
      Ann Rheum Dis 2015;74:757-761. doi:10.1136/annrheumdis-2014-205862
      http://ard.bmj.com/content/74/4/757.full.pdf+html
    • Hermann G, Thon A, Mönkemöller K, Lilienthal E, Klinkert C, Holder M et al
      Comorbidity of Type 1 Diabetes and Juvenile Idiopathic Arthritis
      J Pediatr. 2015 Apr;166(4):930-935.e3. doi: 10.1016/j.jpeds.2014.12.026 
      http://www.ncbi.nlm.nih.gov/pubmed/25641245
    • Félicie Costantino F, Talpin A, Said-Naha R, Goldberg M, Henny J, Chiocchia G, Garchon HJ, Zins M, Breban M
      Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort
      Ann Rheum Dis 2015;74:689-693. doi:10.1136/annrheumdis-2013-204436
      http://ard.bmj.com/content/74/4/689.abstract
    • Howland S, Fisher K
      Looking through the patient lens - Improving best practice for young people with juvenile idiopathic arthritis transitioning into adult care.
      Springerplus. 2015 Mar 5;4:111
      http://www.ncbi.nlm.nih.gov/pubmed/25774337
    • Araujo GR, Fonseca JE, Fujimura PT, Cunha-Junior JP, Silva CH, Mourão AF, Canhão H, Goulart LR, Gonçalves J, Ueira-Vieira C.
      Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.
      Immunol Lett. 2015 Mar 20. pii: S0165-2478(15)00041-3. doi: 10.1016/j.imlet.2015.03.006. [Epub ahead of print]
      http://www.ncbi.nlm.nih.gov/pubmed/25800643

FEBRERO 2015
  • van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
    Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study.
    Pediatr Rheumatol Online J. 2015 Feb 18;13:5.
    http://www.ncbi.nlm.nih.gov/pubmed/25745368
  • Schenck S, Niewerth M, Sengler C, Trauzeddel R, Thon A, Minden K, Klotsche J.
    Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis.
    Scand J Rheumatol. 2015 Mar 6:1-8.
    http://www.ncbi.nlm.nih.gov/pubmed/25742802
  • Chickermane PR, Khubchandani RP.
    Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Clin Exp Rheumatol. 2015 Feb 18.
    http://www.ncbi.nlm.nih.gov/pubmed/25738527
  • Aupiais C, Ilharreborde B, Doit C, Blachier A, Desmarest M, Job-Deslandre C, Mazda K, Faye A, Bonacorsi S, Alberti C, Lorrot M.
    Aetiology of arthritis in hospitalised children: an observational study.
    Arch Dis Child. 2015 Mar 2.
    http://www.ncbi.nlm.nih.gov/pubmed/25732253
  • Shady MM, Fathy HA, Ali A, Youness ER, Fathy GA.
    Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
    J Pediatr (Rio J). 2015 Feb 26.
    http://www.ncbi.nlm.nih.gov/pubmed/25727025
  • Rusak M, Radzikowska U, Glowinska-Olszewska B, Dobrenko E, Piotrowska-Jastrzebska J, Dabrowska M, Bodzenta-Lukaszyk A, Bossowski A, Moniuszko M.
    Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies.
    Pediatr Rheumatol Online J. 2015 Feb 19;13:6.
    http://www.ncbi.nlm.nih.gov/pubmed/25705139 
  • Aguiar CL, Pan N, Adams A, Barinstein L, Lehman TJ.
    Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
    Clin Rheumatol. 2015 Feb 20.
    http://www.ncbi.nlm.nih.gov/pubmed/25697878 
  • Winsz-Szczotka K, Kuźnik-Trocha K, Komosińska-Vassev K, Wisowski G, Gruenpeter A, Lachór-Motyka I, Żegleń B, Lemski W, Olczyk K.
    Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.
    Biochem Biophys Res Commun. 2015 Feb 13.
    http://www.ncbi.nlm.nih.gov/pubmed/25684189
  • Renton W1, Whitehead B.
    Myositis as a presenting feature of systemic onset juvenile idiopathic arthritis.
    J Paediatr Child Health. 2015 Feb;51(2):233.
    http://www.ncbi.nlm.nih.gov/pubmed/25677488
  • Young CM, Horst DM, Murakami JW, Shiels WE 2nd.
    Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis.
    Pediatr Radiol. 2015 Feb 12.
    http://www.ncbi.nlm.nih.gov/pubmed/25672519
  • Nimmrich S, Horneff G.
    Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
    Rheumatol Int. 2015 Mar;35(3):465-70.
    http://www.ncbi.nlm.nih.gov/pubmed/25583050
ENERO 2015
  • Wakil SM, Monies DM, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim EA, Al-Younes B, Shinwari J, Al-Mohanna FA, Meyer BF, Al-Mayouf S.
    Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis.
    Arthritis Rheumatol. 2015 Jan;67(1):288-95. doi: 10.1002/art.38877.
    http://www.ncbi.nlm.nih.gov/pubmed/25220867
  • Lianne Kearsley-Fleet, Kimme L Hyrich, Rebecca Davies, Mark Lunt, and  Taunton R Southwood on behalf of the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
    Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
    Rheumatology first published online January 30, 2015.
    doi:10.1093/rheumatology/keu489
    http://rheumatology.oxfordjournals.org/content/early/2015/01/29/rheumatology.keu489.abstract
  •  Ćalasan MB, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
    Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.
    Ann Rheum Dis. 2015 Feb;74(2):402-7. doi: 10.1136/annrheumdis-2013-203723. Epub 2013 Nov 28.
    http://www.ncbi.nlm.nih.gov/pubmed/24288013
  •  Nimmrich S, Horneff G.
    Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
    Rheumatol Int. 2015 Jan 13. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25583050

DICIEMBRE 2014
  • Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
    Description of active joint count trajectories in juvenile idiopathic arthritis.
    J Rheumatol. 2014 Dec;41(12):2466-73. doi: 10.3899/jrheum.130835
    http://www.ncbi.nlm.nih.gov/pubmed/25274882
  • Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.
    Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Vaccine. 2014 Dec 29. pii: S0264-410X(14)01683-1. doi: 10.1016/j.vaccine.2014.12.030. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25554240 
  • Chiaroni-Clarke RC, Munro JE, Chavez RA, Pezic A, Allen RC, Akikusa JD, Piper SE, Saffery R, Ponsonby AL, Ellis JA.
    Independent confirmation of juvenile idiopathic arthritis genetic risk loci previously identified by immunochip array analysis.
    Pediatr Rheumatol Online J. 2014 Dec 16;12:53. doi: 10.1186/1546-0096-12-53
    http://www.ncbi.nlm.nih.gov/pubmed/25540605 
  • Lundbäck P, Stridh P, Klevenvall L, Jenkins R, Fischer M, Sundberg E, Andersson U, Antoine D, Harris HE.
    Characterization of the inflammatory properties of actively released HMGB1 in juvenile idiopathic arthritis.
    Antioxid Redox Signal. 2014 Dec 22 [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/25532033
  • van Dijkhuizen EP, Wulffraat NM.
    Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    Pediatr Rheumatol Online J. 2014 Dec 11;12:51. doi: 10.1186/1546-0096-12-51
    http://www.ncbi.nlm.nih.gov/pubmed/25525416
  • Brunner H, Lomax KG, Levy S.
    Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis: Comment on the article by Ilowite et al.
    Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38992.
    http://www.ncbi.nlm.nih.gov/pubmed/25512026
  • Ilowite NT for the RAPPORT Investigators.
    Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis.
    Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38991. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25511916
  • Lamot L, Borovecki F, Tambic Bukovac L, Vidovic M, Perica M, Gotovac K, Harjacek M.
    Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.
    PLoS One. 2014 Dec 15;9(12):e115416.
    http://www.ncbi.nlm.nih.gov/pubmed/25506924
  • Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
    Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
    Rheumatology (Oxford). 2014 Dec 10. pii: keu457. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25504896 
  • Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
    Impact of JIA on parents' work absences.
    Rheumatology (Oxford). 2014 Dec 10. pii: keu414. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25504895
  • De Benedetti F1, Brunner H, Ruperto N, Schneider R, Xavier R, Allen R, Brown D, Chaitow J, Pardeo M, Espada G, Gerloni V, Myones B, Frane J, Wang J, Lipman TH, Bharucha KN, Martini A, Lovell D; the Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG)
    Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: Results from the TENDER trial.
    Arthritis Rheumatol. 2014 Dec 10. doi: 10.1002/art.38984. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25504861
  • Salonen PH, Säilä H, Salonen JH, Vuorela M, Kautiainen H, Lyytikäinen O, Kauppi MJ, Leirisalo-Repo M, Repo H.
    Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease.
    Clin Exp Rheumatol. 2014 Nov-Dec;32(6):979-83.
    http://www.ncbi.nlm.nih.gov/pubmed/25436839
  • Bryan AR, Rabinovich CE.
    Enthesitis-related arthritis: time to re-define?
    Curr Rheumatol Rep. 2014 Dec;16(12):466.
    http://www.ncbi.nlm.nih.gov/pubmed/25366933 
  • Weiss JE, Luca NJ, Boneparth A, Stinson
    Assessment and management of pain in juvenile idiopathic arthritis.
    Paediatr Drugs. 2014 Dec;16(6):473-81.
    http://www.ncbi.nlm.nih.gov/pubmed/25331986

NOVIEMBRE 2014
  • Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
    Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
    J Rheumatol. 2014 Nov 29. pii: jrheum.140073. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25433530
  • Salem KM, Radhakrishnan A, Behrbalk E, Boszczyk BM.
    The surgical management of atlanto-axial subluxation in juvenile rheumatoid arthritis.
    Eur Spine J. 2014 Nov 27. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25427669
  • Schulert GS, Grom AA.
    Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies.
    Annu Rev Med. 2014 Nov 5. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25386930
  • van den Broek T, Hoppenreijs E, Meerding J, Scholman R, Otten HG, Swart JF, Martini A, Prakken B, de Jager W.
    Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis.
    Ann Rheum Dis. 2014 Nov 10. pii: annrheumdis-2014-206424. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25384964
  • Adunuri NR, Feldman BM.
    A critical appraisal of studies measuring Quality of Life in Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2014 Nov 10. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25384887
  • Rigante D, Bosco A, Esposito S.
    The Etiology of Juvenile Idiopathic Arthritis.
    Clin Rev Allergy Immunol. 2014 Nov 12. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25384710
  • Bryan AR, Rabinovich CE.
    Enthesitis-Related Arthritis: Time to Re-define?
    Curr Rheumatol Rep. 2014 Dec;16(12):466.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25366933
  • Consolaro A, Schiappapietra B, Dalprà S, Calandra S, Martini A, Ravelli A.
    Optimisation of disease assessments in juvenile idiopathic arthritis.
    Clin Exp Rheumatol. 2014 Nov-Dec;32 Suppl 85(5):126-130.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25365101
  • Shimizu M, Nakagishi Y, Yoshida A, Yachie A.
    Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis.
    J Rheumatol. 2014 Nov;41(11):2328-30.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25362722
  • Guzman J, Gómez-Ramírez O, Jurencak R, Shiff NJ, Berard RA, Duffy CM, Oen K, Petty RE, Benseler SM, Brant R, Tucker LB.
    What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    J Rheumatol. 2014 Nov;41(11):2260-9.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25225279
  • Zhao Y, Wallace C.
    Judicious use of biologicals in juvenile idiopathic arthritis.
    Curr Rheumatol Rep. 2014 Nov;16(11):454.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25218736
  • Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS; REACCH OUT and BBOP Research Consortia.
    The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.
    Arthritis Rheumatol. 2014 Dec;66(12):3463-75
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25200124
  • Funk RS, van Haandel L, Leeder JS, Becker ML.
    Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.
    Arthritis Rheumatol. 2014 Dec;66(12):3476-85.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25186097
  • Akioka S.
    Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis.
    Ann Rheum Dis. 2014 Dec;73(12):e75.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25165031
  • Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
    Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
    Nat Rev Rheumatol. 2014 Nov;10(11):682-690.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25112604
  • Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.
    Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Arthritis Rheumatol. 2014 Nov;66(11):3160-9.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25077692
  • Esposito S, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
    Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
    Expert Rev Vaccines. 2014 Nov;13(11):1387-93.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25066387
  • Shimizu M, Ueno K, Ishikawa S, Tokuhisa Y, Inoue N, Yachie A.
    Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus.
    Rheumatology (Oxford). 2014 Nov;53(11):2120-2.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25065006
  • Weiss PF, Colbert RA, Xiao R, Feudtner C, Beukelman T, DeWitt EM, Pagnini I, Wright TB, Wallace CA.
    Development and retrospective validation of the juvenile spondyloarthritis disease activity index.
    Arthritis Care Res (Hoboken). 2014 Dec;66(12):1775-82.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=PMC4245319
  • Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich  AH, Fall N, Harley JB, Nirmala NR, Grom AA.
    Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
    Arthritis Rheumatol. 2014 Dec;66(12):3486-95.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=25047945
  • Coulson EJ, Hanson HJ, Foster HE.
    What does an adult rheumatologist need to know about juvenile idiopathic arthritis?
    Rheumatology (Oxford). 2014 Dec;53(12):2155-2166.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=24987157
  • Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.
    Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.
    Arthritis Care Res (Hoboken). 2014 Nov;66(11):1703-9.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=24980508
  • Bechtold S, Simon D.
    Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.
    Rheumatol Int. 2014 Nov;34(11):1483-8.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=24760485
OCTUBRE 2014
  • Grom AA.
    Canakinumab for the treatment of systemic juvenile idiopathic arthritis.
    Expert Rev Clin Immunol. 2014 Nov;10(11):1427-35. Epub 2014 Oct 1.
    http://www.ncbi.nlm.nih.gov/pubmed/25269376
  • Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
    Description of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2014 Oct 1. pii: jrheum.130835. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25274882
  • Levy D.
    Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
    J Rheumatol. 2014 Oct;41(10):1903-5. doi: 10.3899/jrheum.140946. No abstract available.
    http://www.ncbi.nlm.nih.gov/pubmed/25275091
  • Brabnikova-Maresova K, Jarosova K, Pavelka K, Stepan JJ.
    Serum sclerostin in adult high-activity patients with juvenile idiopathic arthritis.
    Arthritis Res Ther. 2014 Oct 4;16(5):460. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25280749
  • Jadon D, Shaddick G, Jobling A, Ramanan AV, Sengupta R.
    Clinical outcomes and progression to orthopedic surgery in juvenile versus adult-onset ankylosing spondylitis.
    Arthritis Care Res (Hoboken). 2014 Oct 20. doi: 10.1002/acr.22500. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25331747
  • Selvaag AM, Aulie HA, Lilleby V, Flatø B.
    Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
    Ann Rheum Dis. 2014 Oct 31. pii: annrheumdis-2014-206034. doi: 10.1136/annrheumdis-2014-206034. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25362042
  • Weiss JE, Luca NJ, Boneparth A, Stinson J.
    Assessment and Management of Pain in Juvenile Idiopathic Arthritis.
    Paediatr Drugs. 2014 Oct 21. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25331986
  • Anjali Patwardhan, Michael Gardner , Bert Bachrach, Prasad Bichu, Timothy Joseph Hayes
    The Juvenile Idiopathic Arthritis Patients Run a Higher Risk for Dyslipidemia as Compared to Adults with Arthritis
    Ann Paediatr Rheum. 2014; 3(3): 116-125
    http://www.scopemed.org/?mno=160450
  • Anne M Selvaag1, Hanne A Aulie1, Vibke Lilleby1, Berit Flatø.
    Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
    Ann Rheum Dis doi:10.1136/annrheumdis-2014-206034
    http://ard.bmj.com/content/early/2014/10/31/annrheumdis-2014-206034.abstract
  • Suzanne M.M. Verstappen, Joanna Cobb, Helen E Foster, Bo Fu, Eileen Baildam, Lucy R Wedderburn, Joyce E Davidson, John Ioannou, Alice Chieng, Kimme L Hyrich and Wendy Thomson
    Low socio-economic status is associated with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)
    Accepted manuscript online: 3 SEP 2014 01:20PM EST | DOI: 10.1002/acr.22466
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22466/abstract
  • Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen, and Outi Mäkitie
    High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
    J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.131107
    http://jrheum.org/content/early/2014/10/08/jrheum.131107.abstract
  • Miika Arvonen, Lauri J. Virta, Tytti Pokka, Liisa Kröger, and Paula Vähäsalo
    Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group’s Greater Susceptibility to Infections?
    J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.140348
    http://jrheum.org/content/early/2014/10/08/jrheum.140348.abstract
  • Jaime Guzman, Oralia Gómez-Ramírez, Roman Jurencak, Natalie J. Shiff, Roberta A. Berard, Ciaran M. Duffy, Kiem Oen, Ross E. Petty, Susanne M. Benseler, Rollin Brant, and Lori B. Tucker
    What Matters Most for Patients, Parents, and Clinicians in the Course of Juvenile Idiopathic Arthritis? A Qualitative Study
    J Rheumatol November 2014 41(11):2260-2269; published online before print September 15, 2014, doi:10.3899/jrheum.131536
    http://jrheum.org/content/41/11/2260.abstract
  • Cartwright T, Fraser E, Edmunds S, Wilkinson N, Jacobs K.
    Journeys of adjustment: the experiences of adolescents living with juvenile idiopathic arthritis.
    Child Care Health Dev. 2014 Oct 6. doi: 10.1111/cch.12206. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25287720

SEPTIEMBRE 2014
  • Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, Schanberg LE, Higgins GC, O'Neil KM, Gottlieb BS, Hsu J, Punaro MG, Kimura Y, Hendrickson A.
    Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2014 Sep 1. pii: jrheum.140347. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25179849
  • Chang CY, Meyer RM, Reiff AO.
    Impact of Medication Withdrawal Method on Flare-free Survival in Patients withJuvenile Idiopathic Arthritis on Combination Therapy.
    ArthritisCare Res(Hoboken).2014 Sep 12. doi:10.1002/acr.22477.[Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25220674
  • Cedströmer AL, Ahlqwist M, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
    Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatment.
    Pediatr Rheumatol Online J.2014 Sep 14;12(1):43.
    http://www.ncbi.nlm.nih.gov/pubmed/25249821
  • Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A.
    Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
    Ann Rheum Dis. 2014 Sep;73(9):1689-94. doi: 10.1136/annrheumdis-2013-204902.
    http://www.ncbi.nlm.nih.gov/pubmed/24748630
  • Munro J, Murray K, Boros C, Chaitow J, Allen RC, Akikusa J, Adib N, Piper SE, Singh-Grewal D; Australian Paediatric Rheumatology Group.
    Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis.
    J Paediatr Child Health. 2014 Sep;50(9):663-6. doi: 10.1111/jpc.12462
    http://www.ncbi.nlm.nih.gov/pubmed/25156704
  • Schmeling H1, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G.
    Efficacy and safety of Adalimumab as first and second used biologic agent in juvenile idiopathic arthritis - the German Biologics JIA Registry (BiKeR).
    Arthritis Rheumatol. 2014 Sep; 66(9):2580-2589.
    http://www.ncbi.nlm.nih.gov/pubmed/24942886
  • Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE,Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.
    The randomized placebo phase study of rilonacept in the treatment of systemic juvenile idiopathic arthritis(RAPPORT).
    Arthritis Rheumatol. 2014 Sep; 66(9):2570-2579.
    http://www.ncbi.nlm.nih.gov/pubmed/24839206
  • Moncrieffe H1, Prahalad S, Thompson SD.
    Genetics of juvenile idiopathic arthritis: new tools bring new approaches.
    Curr Opin Rheumatol. 2014 Sep;26(5):579-84. 
    http://www.ncbi.nlm.nih.gov/pubmed/25010442
  • Nirmala N1, Grom A, Gram H.
    Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.
    Curr Opin Rheumatol. 2014 Sep;26(5):543-52. 
    http://www.ncbi.nlm.nih.gov/pubmed/25050926

AGOSTO 2014
  • Murias S, Alcobendas R, Pascual-Salcedo D, Remesal A, Peralta J, Merino R.
    Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience.
    Rheumatology (Oxford). 2014 Aug 7. pii: keu305. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25102859
  • Haverman L, van Oers HA, Maurice-Stam H, Kuijpers TW, Grootenhuis MA, van Rossum MA.
    Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey.
    Pediatr Rheumatol Online J. 2014 Aug 7;12:34.
    http://www.ncbi.nlm.nih.gov/pubmed/25120411
  • Huynh D, Kavanaugh A
    Psoriatic arthritis: current therapy and future approaches.
    Rheumatology (Oxford). 2014 Aug 14. pii: keu237. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25125588
  • Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
    Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
    Nat Rev Rheumatol. 2014 Aug 12. doi: 10.1038/nrrheum.2014.140.
    http://www.ncbi.nlm.nih.gov/pubmed/25112604
  • Albarouni M, Becker I, Horneff G.
    Predictors of response to methotrexate in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2014 Aug 13;12:35. doi: 10.1186/1546-0096-12-35.
    http://www.ncbi.nlm.nih.gov/pubmed/25143761
  • Clin Rev Allergy Immunol. 2014 Aug 1. [Epub ahead of print]
    Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
    Foeldvari I.
    http://www.ncbi.nlm.nih.gov/pubmed/25081063
  • Rheumatol Int. 2014 Aug 3.
    Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.
    Giménez-Roca C1, Iglesias E, Torrente-Segarra V, Bou R, Sánchez-Manubens J, Calzada-Hernández J, Hernández S, Ricart S, Antón J.
    http://www.ncbi.nlm.nih.gov/pubmed/25086629
  • J Rheumatol. 2014 Aug 1.
    Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis.
    Stagi S, Bertini F, Cavalli L, Matucci-Cerinic M, Brandi ML, Falcini F.
    http://www.ncbi.nlm.nih.gov/pubmed/25086083

JULIO 2014
  • Koos B, Twilt M, Kyank U, Fischer-Brandies H, Gassling V, Tzaribachev N.
    Reliability of Clinical Symptoms in Diagnosing Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2014 Jul 1. pii: jrheum.131337. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24986847
  • J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
    Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
    Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
    http://www.ncbi.nlm.nih.gov/pubmed/24931957
  • Coulson EJ1, Hanson HJ1, Foster HE2.
    What does an adult rheumatologist need to know about juvenile idiopathic arthritis?

    Rheumatology (Oxford). 2014 Jul 1. 
    http://www.ncbi.nlm.nih.gov/pubmed/24987157
  • Miyamae T1, Tanaka E, Kishi T, Matsuyama T, Igarashi T, Fujikawa S, Taniguchi A, Momohara S, Yamanaka H.
    Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.

    Mod Rheumatol. 2014 Jul 14:1-5. 
    http://www.ncbi.nlm.nih.gov/pubmed/25019624
  • Davì S1, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite N, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA,Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM,Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group; the Histiocyte Society.
    Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Arthritis Rheumatol. 2014 Jul 7. doi: 10.1002/art.38769. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25041889
  • Arthritis Rheumatol. 2014 Jul 21.
    Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
    Kaufman KM1, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich A, Fall N, Harley JB, Nirmala NR, Grom AA.
    http://www.ncbi.nlm.nih.gov/pubmed/25047945
  • Weiss PF1, Colbert RA, Xiao R, Feudtner C, Beukelman T, Morgan DeWitt E, Pagnini I, Wright TB, Wallace CA.
    Development and retrospective validation of the juvenile spondyloarthritis disease activity (JSpADA) index.
    Arthritis Care Res (Hoboken). 2014 Jul 21. 
    http://www.ncbi.nlm.nih.gov/pubmed/25047959
  • Ahmed S1, Ali SR1, Ishaque S1, Sami N2
    Clinical and biochemical characteristics of children with juvenile idiopathic arthritis.

    J Coll Physicians Surg Pak. 2014 Jul;24(7):498-502. 
    http://www.ncbi.nlm.nih.gov/pubmed/25052974
  • Reinards TH1, Albers HM1, Brinkman DM2, Kamphuis SS3, van Rossum MA4, Girschick HJ5, Wouters C6, Hoppenreijs EP7, Saurenmann RK8, Hinks A9, Ellis JA10, Bakker E11, Verduijn W12, Slagboom P13, Huizinga TW14, Toes RE14, Houwing-Duistermaat JJ15, Ten Cate R1, Schilham MW16.
    CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis.
    Ann Rheum Dis. 2014 Jul 23. 
    http://www.ncbi.nlm.nih.gov/pubmed/25057181
  • Esposito S1, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
    Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
    Expert Rev Vaccines. 2014 Jul 28:1-7. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25066387
  • Lin C1, MacKenzie JD2, Courtier JL2, Gu JT2, Milojevic D3.
    Magnetic resonance imaging findings in juvenile spondyloarthropathy and effects of treatment observed on subsequent imaging.
    Pediatr Rheumatol Online J. 2014 Jul 11;12:25. doi: 10.1186/1546-0096-12-25. eCollection 2014.
    http://www.ncbi.nlm.nih.gov/pubmed/25067925
  • Moore TL1, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.
    Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Clin Exp Rheumatol. 2014 Jul 17. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25068682
  • Minoia F1, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T,Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology 
    Collaborative Study Group, and the Histiocyte Society. 
    Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis A multinational, multicenter study of 362 patients.
    Arthritis Rheumatol. 2014 Jul 30. doi: 10.1002/art.38802. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25077692

JUNIO 2014
  • Nigrovic PA.
    Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
    Arthritis Rheumatol. 2014 Jun;66(6):1405-13
    http://www.ncbi.nlm.nih.gov/pubmed/24623686
  • Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.
    Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.
    J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25079592
  • Consolaro A1, Negro G, Gallo MC, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.
    Defining criteria for disease activity states in non-systemic juvenile idiopathic arthritis based on a three-variable Juvenile Arthritis Disease Activity Score.
    Arthritis Care Res (Hoboken). 2014 Jun 30. doi: 10.1002/acr.22393. [Epub ahead of print]
  • Van Dijkhuizen EH1, Wulffraat NM2.
    Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
    Ann Rheum Dis. 2014 Jun 24. pii: annrheumdis-2014-205265. doi: 10.1136/annrheumdis-2014-205265. [Epub ahead of print]
  • Liu YC, Tu YL, Wu RC, Huang JL, Yao TC
    Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child
    Pediatr Emerg Care. 2014 Jun;30(6):415-7
    http://www.ncbi.nlm.nih.gov/pubmed/24892681
  • Lipstein EA, Dodds CM, Lovell DJ, Denson LA, Britto MT.
    Making decisions about chronic disease treatment: a comparison of parents and their adolescent children.
    Health Expect. 2014 Jun 3. doi: 10.1111/hex.12210. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24889468
  • Ritchlin CT.
    Psoriatic Enthesitis: An Update from the GRAPPA 2013 Annual Meeting.
    J Rheumatol. 2014 Jun;41(6):1220-3. doi: 10.3899/jrheum.140174.
    http://www.ncbi.nlm.nih.gov/pubmed/24882856


MAYO 2014
  • Ortop Traumatol Rehabil. 2014 May 7;16(2):185-95. doi: 10.5604/15093492.1105236.
    Physiotherapy in pauciarticular juvenile idiopathic arthritis. Case study.
    Zuk B1, Kaczor Z2, Zuk-Drążyk B3, Księżopolska-Orłowska K1.
    http://www.ncbi.nlm.nih.gov/pubmed/25041889
  • Sztajnbok F, Boechat NL, Ribeiro SB, Oliveira SK, Sztajnbok DC, Sant'Anna CC.
    Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis
    Pediatr Rheumatol Online J. 2014 May 22;12:17. doi: 10.1186/1546-0096-12-17
     
  • Stevens A, Meyer S, Hanson D, Clayton P, Donn RP.
    Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis
    Arthritis Res Ther. 2014 May 8;16(3):R109. doi: 10.1186/ar4559.
     
  • Sjakste T, Paramonova N, Rumba-Rozenfelde I, Trapina I, Sugoka O, Sjakste N.
    Juvenile Idiopathic Arthritis Subtype- and Sex-specific Associations with Genetic Variants in the PSMA6/PSMC6/PSMA3 Gene Cluster.
    Pediatr Neonatol. 2014 May 26. pii: S1875-9572(14)00063-1. doi: 10.1016/j.pedneo.2014.01.007. [Epub ahead of print]
     
  • Lotfy HM, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MA
    MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.
    Mol Diagn Ther. 2014 May 27. [Epub ahead of print]
  • Bulatović Ćalasan M1, Wulffraat NM.
    Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
    Expert Rev Clin Immunol. 2014 May 26:1-12. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24857620
  • Berntson L.
    Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.
    Clin Rheumatol. 2014 May 23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24852669
  • Guzman J1, Oen K2, Tucker LB1, Huber AM3, Shiff N4, Boire G5, Scuccimarri R6, Berard R7, Tse SM8, Morishita K1, Stringer E3, Johnson N9, Levy DM8, Duffy KW10, Cabral DA1, Rosenberg AM4, Larché M11, Dancey P12, Petty RE1, Laxer RM8, Silverman E8, Miettunen P9, Chetaille AL13, Haddad E14, Houghton K1,Spiegel L8, Turvey SE1, Schmeling H9, Lang B3, Ellsworth J15, Ramsey S3, Bruns A5, Campillo S6, Benseler S9, Chédeville G6, Schneider R8, Yeung R8, Duffy CM10; for the ReACCh-Out investigators.
    The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Ann Rheum Dis. 2014 May 19. pii: annrheumdis-2014-205372. doi: 10.1136/annrheumdis-2014-205372. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24842571
  • Kaminiarczyk-Pyzalka D, Adamczak K, Mikos H, Klimecka I, Moczko J, Niedziela M.
    Serum TNF-alpha levels and indicators of disease activity in children with oligoarticular juvenile idiopathic arthritis(oJIA) in the first year of the disease.
    Clin Lab. 2014;60(5):799-807.
    http://www.ncbi.nlm.nih.gov/pubmed/24839823
  • Brunner HI1, Ruperto N2, Zuber Z3, Keane C4, Harari O4, Kenwright A4, Lu P5, Cuttica R6, Keltsev V7, Xavier RM8, Calvo I9, Nikishina I10, Rubio-Pérez N11,Alexeeva E12, Chasnyk V13, Horneff G14, Opoka-Winiarska V15, Quartier P16, Silva CA17, Silverman E18, Spindler A19, Baildam E20, Gámir ML21, Martin A22,Rietschel C23, Siri D24, Smolewska E25, Lovell D1, Martini A26, De Benedetti F27; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
    Ann Rheum Dis. 2014 May 16. pii: annrheumdis-2014-205351. doi: 10.1136/annrheumdis-2014-205351. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24834925
  • Aoki C1, Inaba Y, Choe H, Kaneko U, Hara R, Miyamae T, Imagawa T, Mori M, Oba MS, Yokota S, Saito T.
    Discrepancy Between Clinical and Radiological Responses to Tocilizumab Treatment in Patients with Systemic-onset Juvenile Idiopathic Arthritis.
    J Rheumatol. 2014 May 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24786929
  • Wallace CA1, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG,Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ.
    Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic ArthritisTreated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors.
    J Rheumatol. 2014 May 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24786928
  • Jiang K1, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
    Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis.
    Arthritis Rheumatol. 2014 May;66(5):1363-71. doi: 10.1002/art.38341.
    http://www.ncbi.nlm.nih.gov/pubmed/24782192
  • Brescia AC1, Simonds MM, McCahan SM, Fawcett PT, Rose CD.
    The Role of Transforming Growth Factor β Signaling in Fibroblast-like Synoviocytes From Patients With Oligoarticular Juvenile Idiopathic Arthritis: Dysregulation of Transforming Growth Factor β Signaling, Including Overexpression of Bone Morphogenetic Protein 4, May Lead to a Chondrocyte Phenotype and May Contribute to Bony Hypertrophy.
    Arthritis Rheumatol. 2014 May;66(5):1352-62. doi: 10.1002/art.38336.
    http://www.ncbi.nlm.nih.gov/pubmed/24782191
  • Leow OM, Lim LK, Ooi PL, Shek LP, Ang EY, Son MB1.
    Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital.
    Singapore Med J. 2014 May;55(5):248-52.
     
  • Lotfy HM1, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MA.
    MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.
    Mol Diagn Ther. 2014 May 27. [Epub ahead of print]

ABRIL 2014
  • Fanaras N1, Parry NS2, Matthews NS3.
    Multidisciplinary Approach in the Management of Absolute Trismus With Bilateral Temporomandibular Joint Replacements for a Patient With Juvenile Idiopathic Arthritis.

    J Oral Maxillofac Surg. 2014 Apr 30. 
    http://www.ncbi.nlm.nih.gov/pubmed/25085804
  • Aulie HA1, Selvaag AM, Günther A, Lilleby V, Molberg O, Hartmann A, Holdaas H, Flatø B.
    Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis.
    Ann Rheum Dis. 2014 Apr 2. doi: 10.1136/annrheumdis-2013-204804. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24695010
  • Ana F. Mourão, Maria J. Santos, José Melo-Gomes, Fernando M. Martins, José A. Costa, Filipa Ramos, Iva Brito, Cátia Duarte, Ricardo Figueira, GuilhermeFigueiredo, Carolina Furtado, Ana Lopes, Margarida Oliveira, Ana Rodrigues, Manuel Salgado, Miguel Sousa, Jamie C. Branco, João E. Fonseca and Helena Canhão
    Using the Juvenile Arthritis Disease Activity Score Based on Erythrocyte Sedimentation Rate or C-Reactive Protein Level: Results From the Portuguese Register
    Arthritis Care Res.2014 Apr 66(4):585–591. doi: 10.1002/acr.22215
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22215/abstract
  • Curr Rheumatol Rep. 2014 Apr;16(4):410. doi: 10.1007/s11926-014-0410-2.
    Importance of adherence in the outcome of juvenile idiopathic arthritis.
    Len CA, Miotto E Silva VB, Terreri MT.
    http://www.ncbi.nlm.nih.gov/pubmed/24504596

MARZO 2014
  • de Oliveira Sato J, Albuquerque Pedrosa Fernandes T, Bicalho do Nascimento C, Corrente JE, Saad-Magalhaes C.
    Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection
    Clin Exp Rheumatol. 2014 Mar-Apr;32(2):291-6.
  • Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Perez N, Silva CA et al.
    A169: cumulative long-term safety, efficacy and patient-reported outcomes in children with juvenile idiopathic arthritis treated with intravenous abatacept: up to 7 years of treatment.
    Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S218-9. doi: 10.1002/art.38595.
  • Otten MH1, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
    Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Ann Rheum Dis. 2014 Mar 18.doi: 10.1136/annrheumdis-2013-204641. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24641940
  • Stagi S, Cavalli L, Signorini C, Bertini F, Cerinic MM, Brandi ML, Falcini F.
    Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone massdeterminants using dual energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.
    Arthritis Res Ther. 2014 Mar 31;16(2):R83. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24684763
  • Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A95. doi: 10.1136/annrheumdis-2013-205124.220.
    Children with juvenile idiopathic arthritis (JIA): findings in videocapillaroscopy.
    Uceda J, Velloso ML, Martínez R, Marenco JL.
    http://www.ncbi.nlm.nih.gov/pubmed/24489354
  • J Rheumatol. 2014 Mar;41(3):547-53. doi: 10.3899/jrheum.130563. Epub 2014 Feb 1.
    Limitations in the Classification of Childhood-onset Rheumatoid Arthritis.
    Ferrell EG1, Ponder LA, Minor LS, Angeles-Han ST, Kennedy CW, Rouster-Stevens KA, Rohani-Pichavant M, Vogler LB, Prahalad S.
    http://www.ncbi.nlm.nih.gov/pubmed/24488421
  • Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
    Current developments in the use of biomarkers for juvenile idiopathic arthritis.
    Duurland CL, Wedderburn LR.
    http://www.ncbi.nlm.nih.gov/pubmed/24445961
  • Duurland CL, Wedderburn LR.
    Current developments in the use of biomarkers for juvenile idiopathic arthritis.
    Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
    http://www.ncbi.nlm.nih.gov/pubmed/24445961
  • Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]
    Definition of improvement in juvenile idiopathic arthritis using the Juvenile Arthritis Disease Activity Score.
    Horneff G, Becker I.
    http://www.ncbi.nlm.nih.gov/pubmed/24599918
  • Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]
    Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
    Geikowski T1, Becker I, Horneff G; on behalf of the German BIKER Registry Collaborative Study Group.
    http://www.ncbi.nlm.nih.gov/pubmed/24599916

FEBRERO 2014
  • J Foot Ankle Res. 2014 Feb 6;7(1):10. doi: 10.1186/1757-1146-7-10.
    An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment.
    Hendry GJ, Turner DE, Gardner-Medwin J, Lorgelly PK, Woodburn J.
    http://www.ncbi.nlm.nih.gov/pubmed/24502508
  • Clin Biochem. 2014 Feb 1. pii: S0009-9120(14)00055-1 [Epub ahead of print]
    Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.
    Winsz-Szczotka K, Komosińska-Vassev K, Kuźnik-Trocha K, Gruenpeter A, Lachór-Motyka I, Olczyk K.
    http://www.ncbi.nlm.nih.gov/pubmed/24495859
  • Indian J Pediatr. 2014 Feb 5. [Epub ahead of print]
    Spirometric Evaluation in Juvenile Idiopathic Arthritis: Data from Eastern India.
    Alam MM1, Ray B, Sarkar S, Mandal O, Mondal R, Hazra A, Das NK.
    http://www.ncbi.nlm.nih.gov/pubmed/24493318
  • Nat Rev Rheumatol. 2014 Feb 4. doi: 10.1038/nrrheum.2014.4. [Epub ahead of print]
    Neural mechanisms underlying the pain of juvenile idiopathic arthritis.
    de Lalouvière LL, Ioannou Y, Fitzgerald M.
    http://www.ncbi.nlm.nih.gov/pubmed/24492386
  • Clin Exp Rheumatol. 2014 Feb 24. [Epub ahead of print]
    Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis.
    Satija M, Yadav TP, Sachdev N, Chhabra A, Jahan A, Dewan V.
    http://www.ncbi.nlm.nih.gov/pubmed/24564946
  • BMC Musculoskelet Disord. 2014 Feb 21;15(1):51. [Epub ahead of print]
    The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis.
    Brabnikova Maresova K, Jarosova K, Pavelka K, Stepan JJ.
    http://www.ncbi.nlm.nih.gov/pubmed/24558956
  • Autoimmunity. 2014 Feb 20. [Epub ahead of print]
    Genetic background of juvenile idiopathic arthritis.
    Chistiakov DA1, Savost'anov KV, Baranov AA.
    http://www.ncbi.nlm.nih.gov/pubmed/24555814
  • Clin J Pain. 2014 Feb 14. [Epub ahead of print]
    Comparison of Average Weekly Pain Using Recalled Paper and Momentary Assessment Electronic Diary Reports in Children with Arthritis.
    Stinson JN, Jibb LA, Lalloo C, Feldman BM, McGrath PJ, Petroz GC, Streiner D, Dupuis A, Gill N, Stevens BJ.
    http://www.ncbi.nlm.nih.gov/pubmed/24535055
  • Nurs Child Young People. 2014 Feb 11;26(1):26-9. doi: 10.7748/ncyp2014.02.26.1.26.e393.
    Juvenile idiopathic arthritis: updated guide to administering methotrexate
    Livermore P.
    http://www.ncbi.nlm.nih.gov/pubmed/24517621
  • Arthritis Rheumatol. 2014 Feb;66(2):470-8. doi: 10.1002/art.38245.
    The p38-Mediated Rapid Down-Regulation of Cell Surface gp130 Expression Impairs Interleukin-6 Signaling in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients.
    Honke N, Ohl K, Wiener A, Bierwagen J, Peitz J, Di Fiore S, Fischer R, Wagner N, Wüller S, Tenbrock K.
    http://www.ncbi.nlm.nih.gov/pubmed/24504821
  • Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
    Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
    Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
    http://www.ncbi.nlm.nih.gov/pubmed/24504820
  • Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G.
    Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
    Arthritis Care Res (Hoboken). 2014 Feb;66(2):253-62. doi: 10.1002/acr.22112.
    http://www.ncbi.nlm.nih.gov/pubmed/23983081
  • Seid M, Huang B, Niehaus S, Brunner HI, Lovell DJ.
    Determinants of health-related quality of life in children newly diagnosed with juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2014 Feb;66(2):263-9. doi: 10.1002/acr.22117.
    http://www.ncbi.nlm.nih.gov/pubmed/23983144
  • Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
    Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
    Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
    http://www.ncbi.nlm.nih.gov/pubmed/24504820
  • Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.
    Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.
    Ann Rheum Dis. 2014 Feb 1;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25.
    http://www.ncbi.nlm.nih.gov/pubmed/23355079
  • Bulatovic Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM.
    Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2014 Feb;53(2):307-12. doi: 10.1093/rheumatology/ket310. Epub 2013 Oct 24.
    http://www.ncbi.nlm.nih.gov/pubmed/24162034
  • Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist URC.
    Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)
    Ann Rheum Dis 2014;73:407-413 doi:10.1136/annrheumdis-2012-201972
    http://ard.bmj.com/content/73/2/407.abstract
  • McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD et al.
    Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
    Ann Rheum Dis 2014;73:349-356 Published Online First: 29 January 2013
    http://ard.bmj.com/content/73/2/349.abstract
  • Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS Jr, Rocha FA.
    A Longterm Prospective Real-life Experience with Leflunomide in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2014 Feb;41(2):338-44. doi: 10.3899/jrheum.130294. Epub 2013 Dec 15.
    http://www.ncbi.nlm.nih.gov/pubmed/24334641
  • Limenis E, Grosbein HA, Feldman BM.
    The relationship between physical activity levels and pain in children with juvenile idiopathic arthritis.
    J Rheumatol. 2014 Feb;41(2):345-51. doi: 10.3899/jrheum.130734. Epub 2013 Dec 15.
    http://www.ncbi.nlm.nih.gov/pubmed/24334648

ENERO 2014
  • Foeldvari I, Tzaribachev N, Cron RQ.
    Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2014 Jan 25;12(1):6. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24461073
  • Weiss PF, Chauvin NA, Klink AJ, Localio R, Feudtner C, Jaramillo D, Colbert RA, Sherry DD, Keren R.
    Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography.
    Arthritis Rheumatol. 2014 Jan; 66(1):218-27. doi: 10.1002/art.38197.
    http://www.ncbi.nlm.nih.gov/pubmed/24449586
  • Kostik MM, Smirnov AM, Demin GS, Scheplyagina LA, Larionova VI.
    Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism.
    Mol Biol Rep. 2014 Jan 12. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24415299
  • Finnegan S, Robson J, Scaife C, McAllister C, Pennington SR, Gibson DS, Rooney ME.
    Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease.
    Arthritis Res Ther. 2014 Jan 13;16(1):R8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24410838
  • Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J.
    Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).
    Ann Rheum Dis. 2014 Jan 3. doi: 10.1136/annrheumdis-2013-204248. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24389297
  • Jiang K, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
    Whole blood gene expression profiling predicts therapeutic response in polyarticular juvenile idiopathic arthritis at 6 months.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38341. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24402890
  • Hugle B, Burgos-Vargas R, Inman RD, O'Shea F, Laxer RM, Stimec J, Whitney-Mahoney K, Duvnjak M, Anderson M, Tse SM.
    Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
    Clin Exp Rheumatol. 2014 Jan 3. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24387974
  • Pastore S, Gortani G, Taddio A, Barbi E.
    Procedural sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis (JIA) should be a standard of care.
    Eur J Pediatr. 2014 Jan 3. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24384792
  • Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
    Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
    Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
    http://www.ncbi.nlm.nih.gov/pubmed/24368009
  • Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
    Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
    Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24347572

DICIEMBRE 2013
  • Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
    Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
    Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
    http://www.ncbi.nlm.nih.gov/pubmed/24368009
  • Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
    Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
    Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24347572
  • Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM.
    Effectiveness of first line use of recombinant IL-1RA treatment in steroid naïve systemic juvenile idiopathic arthritis: Results of a prospective cohort study.
    Arthritis Rheum. 2013 Dec 18. doi: 10.1002/art.38296. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24352936
  • Consolaro A, Ruperto N, Bracciolini G, Frisina A, Gallo MC, Pistorio A, Verazza S, Negro G, Gerloni V, Goldenstein-Schainberg C, Sztajnbok F, Wulffraat NM,Martini A, Ravelli A; for the Paediatric Rheumatology International Trials Organization (PRINTO).
    Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score.
    Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204186. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24347571
  • Rothmund F, Gerss J, Ruperto N, Däbritz J, Wittkowski H, Frosch M, Wulffraat NM, Wedderburn LR, Holzinger D, Gohar F, Vastert SJ, Brik R, Deslandre CJ,Melo-Gomes JA, Magalhães CS, Barcellona R, Russo R, Gattorno M, Martini A, Roth J, Foell D; for the Paediatric Rheumatology International Trials Organization (PRINTO).
    Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22248. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24339418
  • Ringold S, Weiss PF, Colbert RA, Dewitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; for the Juvenile Idiopathic Arthritis Research Committee of the Children's Arthritis and Rheumatology Research Alliance (CARRA).
    Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22259. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24339215
  • Uettwiller F, Perlbarg J, Pinto G, Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Melki I, Wouters C, Prieur AM, Landais P, Polak M, Quartier P.
    Effect of Biologic Treatments on Growth in Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2013 Dec 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24293576
  • Shafferman A, Fontaine KR, Cron RQ, Beukelman T.
    Changes in Body Mass Index in Children with Juvenile Idiopathic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
    J Rheumatol. 2013 Dec 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24293573

NOVIEMBRE 2013
  • McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL.
    Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2013 Nov;52(11):1941-51. doi: 10.1093/rheumatology/ket150
    http://www.ncbi.nlm.nih.gov/pubmed/23630368
  • Zhou J, Tang X, Ding Y, An Y, Zhao X.
    Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
    Pediatr Allergy Immunol. 2013 Nov;24(7):691-6.
    http://www.ncbi.nlm.nih.gov/pubmed/24112428

OCTUBRE 2013
  • Mawani N, Amine B, Rostom S, El Badri D, Ezzahri M, Moussa F, Shyen S, Gueddari S, Wabi M, Shkirat B, Hassouni NH.
    Moroccan parents caring for children with juvenile idiopathic arthritis: positive and negative aspects of their experiences.
    Pediatr Rheumatol Online J. 2013 Oct 20;11(1):39. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24138932
  • Goodman SB, Hwang K, Imrie S.
    High Complication Rate in Revision Total Hip Arthroplasty in Juvenile Idiopathic Arthritis.
    Clin Orthop Relat Res. 2013 Oct 18. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24136805
  • Shyen S, Amine B, Rostom S, El Badri D, Ezzahri M, Mawani N, Moussa F, Gueddari S, Wabi M, Abouqal R, Chkirate B, Hajjaj-Hassouni N.
    Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
    Clin Rheumatol. 2013 Oct 19. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24135889
  • Cedströmer AL, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
    Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis -- an observational study.
    Pediatr Rheumatol Online J. 2013 Oct 17;11(1):37. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24134193
  • Pelegrín L, Casaroli-Marano R, Antón J, Carmen García de Vicuña M, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J, Adán A.
    Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis.
    Ocul Immunol Inflamm. 2013 Oct 16. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24131380

SEPTIEMBRE 2013
  • Castillo-Gallego C, Aydin SZ, Emery P, McGonagle DG, Marzo-Ortega H.
    Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA–B27.
    Arthritis Rheum 2013 Sep;65(9):2274-8.
    http://onlinelibrary.wiley.com/doi/10.1002/art.38050/abstract
  • Ringold S, Weiss PF, Beukelman T, Dewitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK.
    2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications.
    Arthritis Rheum. 2013 Oct;65(10):2499-2512  doi: 10.1002/art.38092.
    http://www.ncbi.nlm.nih.gov/pubmed/24092554

AGOSTO 2013
  • Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML.
    High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
    J Rheumatol. 2013 Aug 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23950184

JULIO 2013
  • Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius A, Sundberg E, Erlandsson Harris H.
    HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration.
    J Rheumatol. 2013 Jul 15. [Epub ahead of print]
  • Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.
    Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.
    J Rheumatol. 2013 Jul;40(7):1191-9. doi: 10.3899/jrheum.121131. Epub 2013 May 15.
  • Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, Pistorio A, Lanni S, Consolaro A, Martini A, Ravelli A.
    Delineating the role of multiple intra-articular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.
    Arthritis Care Res (Hoboken). 2013 Jul;65 (7):1112-20. doi: 10.1002/acr.21947.

JUNIO 2013
  • Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, Ten Cate R, van Suijlekom-Smit LW.
    Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
    Rheumatology (Oxford). 2013 Jun 4. [Epub ahead of print]
  • Hinks A, Cobb J, Marion MC, et al.
    Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.
    Nat Genet. 2013 Jun;45(6):664-9. doi: 10.1038/ng.2614.

MAYO 2013
  • Otten MH, Prince FH, Anink J, Ten Cate R, Hoppenreijs EP, Armbrust W, Koopman-Keemink Y, van Pelt PA, Kamphuis S, Gorter SL,Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.
    Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
    Ann Rheum Dis. 2013 May;72(5):721-7. doi: 10.1136/annrheumdis-2011-201060. Epub 2012 Jun 23.
    http://www.ncbi.nlm.nih.gov/pubmed/22730374
  • Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; for the Paediatric Rheumatology International Trials Organisation (PRINTO).
    Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study.
    Ann Rheum Dis. 2013 May 21. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/ 23696632
  • Pelajo CF, Angeles-Han ST, Prahalad S, Sgarlat CM, Davis TE, Miller LC, Lopez-Benitez JM.
    Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis.
    Rheumatol Int. 2013 May 10. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23660749
  • Saha A, Chopra Y, Theis JD, Vrana JA, Sethi S.
    AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis.
    Am J Kidney Dis. 2013 May 9. pii: S0272-6386 (13) 00675-6.
    doi: 10.1053/j.ajkd.2013.02.377. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23664546
  • Dey S, Jahan A, Yadav TP, Bhagwani DK, Sachdev N.
    Measurement of Bone Mineral Density by Dual Energy X-ray Absorptiometry in Juvenile Idiopathic Arthritis.
    Indian J Pediatr. 2013 May 4. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23645223
  • Leegaard A, Lomholt JJ, Thastum M, Herlin T.
    Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-sectional Study.
    J Rheumatol. 2013 May 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23637324
  • Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, Nielsen S, Rygg M; for the Nordic Study Group of Paediatric Rheumatology.
    HLA-B27 Predicts a More Chronic Disease Course in an 8-year Followup Cohort of Patients with Juvenile Idiopathic Arthritis.
    J Rheumatol 2013 May;40(5):725-731.
    http://www.ncbi.nlm.nih.gov/pubmed/23547219
  • Lomholt JJ, Thastum M, Herlin T.
    Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.
    Pediatr Rheumatol Online J. 2013 May 6;11(1):21. doi: 10.1186/1546-0096-11-21.
    http://www.ncbi.nlm.nih.gov/pubmed/23641813
  • Kröger L, Piippo-Savolainen E, Tyrväinen E, Penttilä P, Kröger H.
    Osteochondral lesions in children with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2013 May 1;11(1):18. doi: 10.1186/1546-0096-11-18.
    http://www.ncbi.nlm.nih.gov/pubmed/23634779
  • Kimura Y, Weiss JE, Haroldson KL et al.
    Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis†
    Arthritis Care Res (Hoboken). 2013 May; 65:745-52.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.21889/abstract
  • Hurd A, Beukelman T.
    Infectious complications in juvenile idiopathic arthritis.
    Curr Rheumatol Rep. 2013 May;15:327. doi: 10.1007/s11926-013-0327-1.
    http://www.ncbi.nlm.nih.gov/pubmed/23529583
  • Tuompo R, Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M.
    Reactive arthritis following Salmonella infection: a population-based study.
    Scand J Rheumatol. 2013 May;42(3):196-202. doi: 10.3109/03009742.2012.739201.
  • Bertilsson L, Andersson-Gäre B, Fasth A, Petersson IF, Forsblad-d'Elia H.
    Disease Course, Outcome, and Predictors of Outcome in a Population-based Juvenile Chronic Arthritis Cohort Followed for 17 Years.
    J Rheumatol. 2013 May;40(5):715-24. doi: 10.3899/jrheum.120602.

ABRIL 2013
  • Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, Roth J, Wedderburn LR.
    A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein
    Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23620557
  • Collado P, Naredo E, Calvo C, Gamir ML, Calvo I, García ML, Merino R, Graña J, Bustabab S, Garrido J; on behalf of the ECO-JIA Study Group.
    Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23620551
  • Prince FH, van Suijlekom-Smit LW.
    Cost of Biologics in the Treatment of Juvenile Idiopathic Arthritis: A Factor not to be Overlooked.
    Paediatr Drugs. 2013 Apr 21. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23606042
  • Hinks A, Cobb J, Marion MC et al.
    Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.
    Nat Genet. 2013 Apr 21. doi: 10.1038/ng.2614. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23603761
  • Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ.
    Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009.
    J Rheumatol. 2013 Apr 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23588938
  • Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.
    Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
    Cytokine. 2013 Apr 3. pii: S1043-4666(13)00109-9. doi: 10.1016/j.cyto.2013.03.007. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23561929
  • Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, Ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW.
    Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
    Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24.
    http://www.ncbi.nlm.nih.gov/pubmed/23267169
  • De Sanctis S, Marcovecchio ML, Gaspari S, Del Torto M, Mohn A, Chiarelli F, Breda L.
    Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2013 Apr 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23547210
  • Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP.
    Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
    Ann Rheum Dis. 2013 Apr;72(4):517-24. doi: 10.1136/annrheumdis-2011-201244. Epub 2012 May 5.
    http://www.ncbi.nlm.nih.gov/pubmed/22562972

MARZO 2013
  • Głowińska-Olszewska B, Bossowski A, Dobreńko E, Hryniewicz A, Konstantynowicz J, Milewski R, Luczyński W, Piotrowska-Jastrzębska J, Kowal-Bielecka O.
    Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis.
    Mediators Inflamm. 2013;2013:436702. doi: 10.1155/2013/436702. Epub 2013 Mar 11.
    http://www.ncbi.nlm.nih.gov/pubmed/23554546
  • Butbul Aviel Y, Tyrrell P, Schneider R, Dhillon S, Feldman BM, Laxer R, Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman E.
    Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
    Pediatr Rheumatol Online J. 2013 Mar 15;11:11. doi: 10.1186/1546-0096-11-11.
    http://www.ncbi.nlm.nih.gov/pubmed/23497068
  • Coulson EJ, Ng WF, Goff I, Foster HE.
    Cardiovascular risk in juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2013 Mar 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23502074
  • Stoll ML, Morlandt AB, Teerawattanapong S, Young D, Waite PD, Cron RQ.
    Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.
    Rheumatology (Oxford). 2013 Mar;52(3):554-9. doi: 10.1093/rheumatology/kes318. Epub 2012 Dec 5.
    http://rheumatology.oxfordjournals.org/content/52/3/554.full.pdf+html

FEBRERO 2013
  • Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, Gattorno M, Picco P, Ruperto N, Malattia C, Martini A, Ravelli A.
    Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept.
    J Rheumatol. 2013 Feb;40(2):192-200. doi: 10.3899/jrheum.120842. Epub 2012 Dec 1.
    http://www.ncbi.nlm.nih.gov/pubmed/23204218

ENERO 2013
  • Ungar WJ, Costa V, Burnett HF, Feldman BM, Laxer RM.
    The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: A systematic review.Semin Arthritis Rheum. 2013 Jan 18. pii: S0049-0172(12)00263-6. doi: 10.1016/j.semarthrit. 2012.10.006. [Epub ahead of print]
  • Russo RA, Katsicas MM.
    Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome.
    J Rheumatol 2013 Jan 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23322471

DICIEMBRE 2012
  • De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell DJ, and Martini A, for the PRINTO and PRCSG.
    Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis.
    N Engl J Med 2012; 367:2385-2395. December 20, 2012 DOI: 10.1056/NEJMoa1112802
  • Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A and Lovell DJ, M.D., M.P.H. fo rthe PRINTO and PRCSG.
    Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
    N Engl J Med 2012; 367:2396-2406. December 20, 2012 DOI: 10.1056/NEJMoa1205099

NOVIEMBRE 2012
  • Otten MH, Anink J,Spronk S,van Suijlekom-Smit LW.
    Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
    Ann Rheum Dis 2012 Nov 21. [Epub ahead of print]

SEPTIEMBRE 2012
  • Stoll ML, Sharpe T, Beukelman T, Good J, Young D, Cron RQ.
    Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
    J Rheumatol 2012 Sep;39(9):1880-7. doi: 10.3899/jrheum.111441. Epub 2012 May 15.
    http://www.ncbi.nlm.nih.gov/pubmed/22589268
  • Burnett HF, Regier DA, Feldman BM, Miller FA, Ungar WJ.
    Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
    Arthritis Care Res (Hoboken). 2012 Sep;64(9):1382-91. doi: 10.1002/acr.21698.
    http://www.ncbi.nlm.nih.gov/pubmed/22504893
  • Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ.
    Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
    Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64. doi: 10.1002/acr.21709.
    http://www.ncbi.nlm.nih.gov/pubmed/22511558
  • Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G.
    Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
    Arthritis Care Res (Hoboken). 2012 Sep;64(9):1349-56. doi: 10.1002/acr.21697
    http://www.ncbi.nlm.nih.gov/pubmed/22649024

JULIO 2012
  • DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, Schikler KN, Vehe RK, Weiss JE, Weiss P, Ilowite NT, Wallace CA; Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance.
    Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2012 Jul;64(7):1001-10. doi: 10.1002/acr.21625.
    http://www.ncbi.nlm.nih.gov/pubmed/22290637

JUNIO 2012
  • Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.
    Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
    Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.
    http://www.ncbi.nlm.nih.gov/pubmed/22183975

ABRIL 2012
  • Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, Dörner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K.
    Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
    Ann Rheum Dis. 2012 Apr;71 Suppl 2:i2-45.
    http://www.ncbi.nlm.nih.gov/pubmed/22460137

FEBRERO 2012
  • Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, Kopp I, Krauspe R, Markus B, Michels H, Schneider M, Singendonk W, Sitter H, Spamer M, Wagner N, Niehues T.
    Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.
    Clin Immunol. 2012 Feb;142(2):176-93. Epub 2011 Oct 26.
    http://www.ncbi.nlm.nih.gov/pubmed/22154868

Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.

Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.

J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/pubmed/25079592

PATROCINADORES

Área de Socios